false--06-29 Q3 2020 2020-03-28 0000719733 58000 609000 0 0 25000000 25000000 10760000 10760000 10760000 10760000 P5Y P7Y P3Y P4Y 0000719733 2019-06-30 2020-03-28 0000719733 2020-05-04 0000719733 2019-06-29 0000719733 2020-03-28 0000719733 2018-12-30 2019-03-30 0000719733 2018-07-01 2019-03-30 0000719733 2019-12-29 2020-03-28 0000719733 2018-12-29 0000719733 2018-06-30 0000719733 2018-09-29 0000719733 us-gaap:RetainedEarningsMember 2018-07-01 2019-03-30 0000719733 us-gaap:CommonStockMember 2020-03-28 0000719733 us-gaap:CommonStockMember 2019-12-29 2020-03-28 0000719733 us-gaap:RetainedEarningsMember 2018-09-29 0000719733 us-gaap:CommonStockMember 2018-06-30 0000719733 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-06-30 0000719733 2019-09-28 0000719733 us-gaap:RetainedEarningsMember 2019-09-28 0000719733 us-gaap:CommonStockMember 2019-06-30 2020-03-28 0000719733 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-09-29 0000719733 us-gaap:RetainedEarningsMember 2018-12-29 0000719733 us-gaap:CommonStockMember 2018-12-30 2019-03-30 0000719733 us-gaap:CommonStockMember 2019-09-28 0000719733 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-03-28 0000719733 us-gaap:RetainedEarningsMember 2019-06-29 0000719733 us-gaap:CommonStockMember 2018-09-29 0000719733 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-06-29 0000719733 us-gaap:RetainedEarningsMember 2018-12-30 2019-03-30 0000719733 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-12-30 2019-03-30 0000719733 us-gaap:RetainedEarningsMember 2019-12-29 2020-03-28 0000719733 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-07-01 2019-03-30 0000719733 us-gaap:CommonStockMember 2019-06-29 0000719733 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-06-30 2020-03-28 0000719733 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-09-28 0000719733 us-gaap:CommonStockMember 2018-07-01 2019-03-30 0000719733 us-gaap:RetainedEarningsMember 2019-06-30 2020-03-28 0000719733 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-12-29 2020-03-28 0000719733 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-12-29 0000719733 us-gaap:RetainedEarningsMember 2020-03-28 0000719733 us-gaap:CommonStockMember 2018-12-29 0000719733 us-gaap:RetainedEarningsMember 2018-06-30 0000719733 2019-06-30 0000719733 us-gaap:LineOfCreditMember ktcc:OneMonthLondonInterbankOfferedRateMember 2019-06-30 2020-03-28 0000719733 ktcc:DebtInstrumentBasisSpreadonVariableRateScenarioOneMember us-gaap:LineOfCreditMember ktcc:FixedRateMember 2019-06-30 2020-03-28 0000719733 srt:MinimumMember 2019-06-29 0000719733 us-gaap:SubsequentEventMember 2022-01-02 2022-04-02 0000719733 ktcc:WellsFargoBankMember 2020-03-05 0000719733 2018-09-30 0000719733 srt:MinimumMember 2020-03-28 0000719733 ktcc:EquipmentTermLoanDomain 2019-06-30 2020-03-28 0000719733 us-gaap:LineOfCreditMember ktcc:FederalFundsRateMember 2019-06-30 2020-03-28 0000719733 ktcc:WellsFargoBankMember 2019-11-20 0000719733 ktcc:EquipmentTermLoanDomain 2020-03-28 0000719733 ktcc:DebtInstrumentBasisSpreadonVariableRateScenarioTwoMember us-gaap:LineOfCreditMember ktcc:FixedRateMember 2019-06-30 2020-03-28 0000719733 us-gaap:LongTermDebtMember 2020-03-28 0000719733 ktcc:EquipmentTermLoanDomain 2019-06-29 0000719733 ktcc:DebtInstrumentBasisSpreadonVariableRateScenarioThreeMember us-gaap:LineOfCreditMember ktcc:FixedRateMember 2019-06-30 2020-03-28 0000719733 ktcc:EquipmentTermLoanDomain 2016-12-28 0000719733 srt:MaximumMember 2020-03-28 0000719733 srt:MaximumMember 2019-06-29 0000719733 2019-09-05 0000719733 2017-07-02 2017-09-30 0000719733 us-gaap:StockAppreciationRightsSARSMember 2018-12-30 2019-03-30 0000719733 us-gaap:StockAppreciationRightsSARSMember 2019-06-30 2020-03-28 0000719733 us-gaap:StockAppreciationRightsSARSMember 2019-12-29 2020-03-28 0000719733 us-gaap:StockAppreciationRightsSARSMember 2018-07-01 2019-03-30 0000719733 us-gaap:StockAppreciationRightsSARSMember 2018-07-26 2018-07-27 0000719733 us-gaap:StockAppreciationRightsSARSMember 2018-07-27 0000719733 us-gaap:StockAppreciationRightsSARSMember 2019-07-25 0000719733 us-gaap:StockAppreciationRightsSARSMember 2019-07-24 2019-07-25 0000719733 us-gaap:DesignatedAsHedgingInstrumentMember 2018-12-29 0000719733 us-gaap:DesignatedAsHedgingInstrumentMember 2019-09-28 0000719733 us-gaap:DesignatedAsHedgingInstrumentMember 2020-03-28 0000719733 us-gaap:DesignatedAsHedgingInstrumentMember 2018-12-30 2019-03-30 0000719733 us-gaap:InterestRateSwapMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-12-29 2020-03-28 0000719733 us-gaap:InterestRateSwapMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-09-28 0000719733 us-gaap:ForwardContractsMember us-gaap:DesignatedAsHedgingInstrumentMember 2018-12-29 0000719733 us-gaap:InterestRateSwapMember us-gaap:DesignatedAsHedgingInstrumentMember 2018-09-29 0000719733 us-gaap:ForwardContractsMember us-gaap:DesignatedAsHedgingInstrumentMember 2018-12-30 2019-03-30 0000719733 us-gaap:ForwardContractsMember us-gaap:DesignatedAsHedgingInstrumentMember 2018-09-29 0000719733 us-gaap:ForwardContractsMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-03-28 0000719733 us-gaap:ForwardContractsMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-12-29 2020-03-28 0000719733 us-gaap:InterestRateSwapMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-03-28 0000719733 us-gaap:DesignatedAsHedgingInstrumentMember 2019-12-29 2020-03-28 0000719733 us-gaap:InterestRateSwapMember us-gaap:DesignatedAsHedgingInstrumentMember 2018-12-30 2019-03-30 0000719733 us-gaap:ForwardContractsMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-09-28 0000719733 us-gaap:InterestRateSwapMember us-gaap:DesignatedAsHedgingInstrumentMember 2018-12-29 0000719733 us-gaap:DesignatedAsHedgingInstrumentMember 2018-09-29 0000719733 currency:USD us-gaap:SubsequentEventMember 2021-04-03 0000719733 currency:USD us-gaap:SubsequentEventMember 2022-01-01 0000719733 us-gaap:SubsequentEventMember 2020-12-26 0000719733 currency:MXN us-gaap:SubsequentEventMember 2020-12-26 0000719733 currency:MXN us-gaap:SubsequentEventMember 2020-09-26 0000719733 currency:MXN us-gaap:SubsequentEventMember 2020-06-27 0000719733 currency:USD us-gaap:SubsequentEventMember 2020-06-27 0000719733 currency:MXN us-gaap:SubsequentEventMember 2021-07-03 0000719733 us-gaap:SubsequentEventMember 2020-06-27 0000719733 currency:USD us-gaap:SubsequentEventMember 2020-09-26 0000719733 currency:USD us-gaap:SubsequentEventMember 2020-12-26 0000719733 us-gaap:SubsequentEventMember 2020-09-26 0000719733 currency:MXN us-gaap:SubsequentEventMember 2022-01-01 0000719733 us-gaap:SubsequentEventMember 2021-04-03 0000719733 currency:USD us-gaap:SubsequentEventMember 2021-10-02 0000719733 us-gaap:SubsequentEventMember 2021-07-03 0000719733 currency:USD us-gaap:SubsequentEventMember 2021-07-03 0000719733 us-gaap:SubsequentEventMember 2022-01-01 0000719733 us-gaap:SubsequentEventMember 2021-10-02 0000719733 currency:MXN us-gaap:SubsequentEventMember 2021-10-02 0000719733 currency:MXN us-gaap:SubsequentEventMember 2021-04-03 0000719733 2019-11-06 0000719733 us-gaap:LineOfCreditMember 2019-11-06 0000719733 us-gaap:ForwardContractsMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-06-29 0000719733 us-gaap:DesignatedAsHedgingInstrumentMember 2019-06-30 2020-03-28 0000719733 us-gaap:ForwardContractsMember us-gaap:DesignatedAsHedgingInstrumentMember 2018-07-01 2019-03-30 0000719733 us-gaap:InterestRateSwapMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-06-30 2020-03-28 0000719733 us-gaap:DesignatedAsHedgingInstrumentMember 2018-07-01 2019-03-30 0000719733 us-gaap:DesignatedAsHedgingInstrumentMember 2018-06-30 0000719733 us-gaap:InterestRateSwapMember us-gaap:DesignatedAsHedgingInstrumentMember 2018-06-30 0000719733 us-gaap:InterestRateSwapMember us-gaap:DesignatedAsHedgingInstrumentMember 2018-07-01 2019-03-30 0000719733 us-gaap:ForwardContractsMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-06-30 2020-03-28 0000719733 us-gaap:DesignatedAsHedgingInstrumentMember 2019-06-29 0000719733 us-gaap:InterestRateSwapMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-06-29 0000719733 us-gaap:ForwardContractsMember us-gaap:DesignatedAsHedgingInstrumentMember 2018-06-30 0000719733 us-gaap:OtherCurrentLiabilitiesMember us-gaap:InterestRateSwapMember 2020-03-28 0000719733 us-gaap:OtherCurrentLiabilitiesMember us-gaap:ForwardContractsMember 2019-06-29 0000719733 us-gaap:OtherCurrentAssetsMember us-gaap:ForwardContractsMember 2020-03-28 0000719733 ktcc:OtherLongTermLiabilitiesMember us-gaap:ForwardContractsMember 2020-03-28 0000719733 us-gaap:OtherCurrentAssetsMember us-gaap:InterestRateSwapMember 2019-06-29 0000719733 us-gaap:OtherCurrentAssetsMember us-gaap:InterestRateSwapMember 2020-03-28 0000719733 ktcc:OtherLongTermAssetsMember us-gaap:ForwardContractsMember 2020-03-28 0000719733 us-gaap:OtherCurrentLiabilitiesMember us-gaap:InterestRateSwapMember 2019-06-29 0000719733 ktcc:OtherLongTermAssetsMember us-gaap:ForwardContractsMember 2019-06-29 0000719733 us-gaap:OtherCurrentAssetsMember us-gaap:ForwardContractsMember 2019-06-29 0000719733 ktcc:OtherLongTermLiabilitiesMember us-gaap:ForwardContractsMember 2019-06-29 0000719733 us-gaap:OtherCurrentLiabilitiesMember us-gaap:ForwardContractsMember 2020-03-28 0000719733 ktcc:OtherLongTermLiabilitiesMember us-gaap:InterestRateSwapMember 2020-03-28 0000719733 ktcc:OtherLongTermLiabilitiesMember us-gaap:InterestRateSwapMember 2019-06-29 0000719733 us-gaap:ForwardContractsMember us-gaap:FairValueInputsLevel1Member 2019-06-29 0000719733 us-gaap:InterestRateSwapMember us-gaap:FairValueInputsLevel3Member 2019-06-29 0000719733 us-gaap:ForwardContractsMember us-gaap:FairValueInputsLevel2Member 2019-06-29 0000719733 us-gaap:ForwardContractsMember 2019-06-29 0000719733 us-gaap:InterestRateSwapMember us-gaap:FairValueInputsLevel1Member 2019-06-29 0000719733 us-gaap:ForwardContractsMember us-gaap:FairValueInputsLevel3Member 2019-06-29 0000719733 us-gaap:InterestRateSwapMember 2019-06-29 0000719733 us-gaap:InterestRateSwapMember us-gaap:FairValueInputsLevel2Member 2019-06-29 0000719733 us-gaap:ForwardContractsMember us-gaap:FairValueInputsLevel3Member 2020-03-28 0000719733 us-gaap:InterestRateSwapMember us-gaap:FairValueInputsLevel2Member 2020-03-28 0000719733 us-gaap:InterestRateSwapMember us-gaap:FairValueInputsLevel1Member 2020-03-28 0000719733 us-gaap:InterestRateSwapMember us-gaap:FairValueInputsLevel3Member 2020-03-28 0000719733 us-gaap:InterestRateSwapMember 2020-03-28 0000719733 us-gaap:ForwardContractsMember us-gaap:FairValueInputsLevel2Member 2020-03-28 0000719733 us-gaap:ForwardContractsMember us-gaap:FairValueInputsLevel1Member 2020-03-28 0000719733 us-gaap:ForwardContractsMember 2020-03-28 0000719733 us-gaap:OffMarketFavorableLeaseMember 2020-03-28 0000719733 us-gaap:OffMarketFavorableLeaseMember 2019-06-30 2020-03-28 0000719733 us-gaap:OffMarketFavorableLeaseMember 2019-06-29 0000719733 us-gaap:NoncompeteAgreementsMember 2019-06-29 0000719733 us-gaap:OffMarketFavorableLeaseMember 2019-03-31 2019-06-29 0000719733 us-gaap:CustomerRelationshipsMember 2019-06-29 0000719733 us-gaap:NoncompeteAgreementsMember 2019-03-31 2019-06-29 0000719733 us-gaap:CustomerRelationshipsMember 2019-06-30 2020-03-28 0000719733 us-gaap:CustomerRelationshipsMember 2019-03-31 2019-06-29 0000719733 2019-03-31 2019-06-29 0000719733 srt:MinimumMember us-gaap:OffMarketFavorableLeaseMember 2019-06-30 2020-03-28 0000719733 srt:MinimumMember us-gaap:NoncompeteAgreementsMember 2019-06-30 2020-03-28 0000719733 srt:MaximumMember us-gaap:NoncompeteAgreementsMember 2019-06-30 2020-03-28 0000719733 srt:MaximumMember us-gaap:OffMarketFavorableLeaseMember 2019-06-30 2020-03-28 0000719733 us-gaap:TransferredOverTimeMember 2018-07-01 2019-03-30 0000719733 us-gaap:TransferredAtPointInTimeMember 2018-12-30 2019-03-30 0000719733 us-gaap:TransferredOverTimeMember 2019-12-29 2020-03-28 0000719733 us-gaap:TransferredOverTimeMember 2019-06-30 2020-03-28 0000719733 us-gaap:TransferredAtPointInTimeMember 2019-12-29 2020-03-28 0000719733 us-gaap:TransferredAtPointInTimeMember 2019-06-30 2020-03-28 0000719733 us-gaap:TransferredOverTimeMember 2018-12-30 2019-03-30 0000719733 us-gaap:TransferredAtPointInTimeMember 2018-07-01 2019-03-30 0000719733 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2019-12-29 2020-03-28 0000719733 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2019-06-30 2020-03-28 0000719733 us-gaap:CostOfSalesMember 2019-12-29 2020-03-28 0000719733 us-gaap:CostOfSalesMember 2019-06-30 2020-03-28 0000719733 ktcc:OtherLongTermLiabilitiesMember 2020-03-28 0000719733 us-gaap:OtherCurrentLiabilitiesMember 2020-03-28 xbrli:shares xbrli:pure iso4217:USD iso4217:USD xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
____________________________________________________________
FORM 10-Q
____________________________________________________________
☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934
FOR THE QUARTERLY PERIOD ENDED MARCH 28, 2020
OR
☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934
FOR THE PERIOD FROM TO .
Commission File Number 0-11559
____________________________________________________________
KEY TRONIC CORP ORATION
(Exact name of registrant as specified in its charter)
____________________________________________________________

Washington | 91-0849125
(State of Incorporation) | (I.R.S. Employer Identification No.)

N. 4424 Sullivan Road
Spokane Valley, Washington 99216
(509) 928-8000
____________________________________________________________
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements during the past 90 days. Yes ☒ No ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulations S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes x No ¨
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer |  | ☐ |  | Accelerated filer |  | ☒
Non-accelerated filer |  | ☐ |  | Smaller reporting company |  | ☒
Emerging growth company |  | ☐ |  |  |  |

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒
Securities registered pursuant to Section 12(b) of the Act:

Title of each class | Trading Symbol | Name of each exchange on which registered
Common Stock, no par value | KTCC | NASDAQ Global Market

As of May 4, 2020, 10,759,680 shares of common stock, no par value (the only class of common stock), were outstanding.

KEY TRONIC CORPORATION
Index

|  | Page No.
PART I. | FINANCIAL INFORMATION: |
Item 1. | Financial Statements (Unaudited): | 3
| Condensed Consolidated Balance Sheets | 3
| Condensed Consolidated Statements of Income (Loss) | 4
| Condensed Consolidated Statements of Comprehensive Income (Loss) | 5
| Condensed Consolidated Statements of Cash Flows | 6
| Condensed Consolidated Statements of Shareholders’ Equity | 7
| Notes to Condensed Consolidated Financial Statements | 8-21
Item 2. | Management’s Discussion and Analysis of Financial Condition and Results of Operations | 21-34
Item 3. | Quantitative and Qualitative Disclosures about Market Risk | 34
Item 4. | Controls and Procedures | 34
PART II. | OTHER INFORMATION: |
Item 1. | Legal Proceedings | 35
Item 1A. | Risk Factors | 35
Item 2. | Unregistered Sales of Equity Securities and Use of Proceeds* |
Item 3. | Defaults upon Senior Securities* |
Item 4. | Mine Safety Disclosures* |
Item 5. | Other Information* |
Item 6. | Exhibits | 35
Signatures | 36

* Items are not applicable
“We,” “us,” “our,” “Company,” “KeyTronicEMS” and “KeyTronic,” unless the context otherwise requires, means Key Tronic Corporation and its subsidiaries.

PART I: FINANCIAL INFORMATION
Item 1: Financial Statements
KEY TRONIC CORPORATION AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
(Unaudited, in thousands; except share data)

| March 28, 2020 |  | June 29, 2019
ASSETS |  |  |
Current assets: |  |  |
Cash and cash equivalents | $ | 1,302 |  |  | $ | 601 |
Trade receivables, net of allowance for doubtful accounts of $609 and $58 | 77,329 |  |  | 58,429 |
Contract assets | 17,681 |  |  | 22,161 |
Inventories, net | 114,052 |  |  | 100,431 |
Other | 19,597 |  |  | 16,477 |
Total current assets | 229,961 |  |  | 198,099 |
Property, plant and equipment, net | 30,594 |  |  | 29,413 |
Operating lease right-of-use assets, net | 15,347 |  |  | — |
Other assets: |  |  |
Deferred income tax asset | 9,825 |  |  | 7,840 |
Other intangible assets, net | — |  |  | 657 |
Other | 2,676 |  |  | 2,301 |
Total other assets | 12,501 |  |  | 10,798 |
Total assets | $ | 288,403 |  |  | $ | 238,310 |
LIABILITIES AND SHAREHOLDERS’ EQUITY |  |  |
Current liabilities: |  |  |
Accounts payable | $ | 71,893 |  |  | $ | 73,571 |
Accrued compensation and vacation | 6,702 |  |  | 6,759 |
Current portion of debt, net | 7,508 |  |  | 5,841 |
Other | 15,470 |  |  | 7,233 |
Total current liabilities | 101,573 |  |  | 93,404 |
Long-term liabilities: |  |  |
Term loans | 5,210 |  |  | 7,091 |
Revolving loan | 57,236 |  |  | 23,356 |
Operating lease liabilities | 10,327 |  |  | — |
Other long-term obligations | 1,117 |  |  | — |
Total long-term liabilities | 73,890 |  |  | 30,447 |
Total liabilities | 175,463 |  |  | 123,851 |
Commitments and contingencies (Note 9) |  |  |
Shareholders’ equity: |  |  |
Common stock, no par value—shares authorized 25,000; issued and outstanding 10,760 and 10,760 shares, respectively | 46,880 |  |  | 46,680 |
Retained earnings | 68,639 |  |  | 65,353 |
Accumulated other comprehensive gain (loss) | (2,579 | ) |  | 2,426 |
Total shareholders’ equity | 112,940 |  |  | 114,459 |
Total liabilities and shareholders’ equity | $ | 288,403 |  |  | $ | 238,310 |

See accompanying notes to consolidated financial statements.
3

KEY TRONIC CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF INCOME (LOSS)
(Unaudited, in thousands, except share and per share amounts)

| Three Months Ended |  | Nine Months Ended
| March 28, 2020 |  | March 30, 2019 |  | March 28, 2020 |  | March 30, 2019
Net sales | $ | 111,455 |  |  | $ | 107,954 |  |  | $ | 333,462 |  |  | $ | 358,463 |
Cost of sales | 102,207 |  |  | 101,147 |  |  | 306,819 |  |  | 332,243 |
Gross profit | 9,248 |  |  | 6,807 |  |  | 26,643 |  |  | 26,220 |
Research, development and engineering expenses | 1,749 |  |  | 1,398 |  |  | 5,129 |  |  | 4,955 |
Selling, general and administrative expenses | 5,735 |  |  | 5,497 |  |  | 15,713 |  |  | 16,184 |
Impairment of goodwill and intangibles | — |  |  | 12,448 |  |  | — |  |  | 12,448 |
Total operating expenses | 7,484 |  |  | 19,343 |  |  | 20,842 |  |  | 33,587 |
Operating income (loss) | 1,764 |  |  | (12,536 | ) |  | 5,801 |  |  | (7,367 | )
Interest expense, net | 754 |  |  | 720 |  |  | 1,988 |  |  | 2,105 |
Income (loss) before income taxes | 1,010 |  |  | (13,256 | ) |  | 3,813 |  |  | (9,472 | )
Income tax provision (benefit) | 100 |  |  | (1,275 | ) |  | 527 |  |  | (673 | )
Net income (loss) | $ | 910 |  |  | $ | (11,981 | ) |  | $ | 3,286 |  |  | $ | (8,799 | )
Net income (loss) per share — Basic | $ | 0.08 |  |  | $ | (1.11 | ) |  | $ | 0.31 |  |  | $ | (0.82 | )
Weighted average shares outstanding — Basic | 10,760 |  |  | 10,760 |  |  | 10,760 |  |  | 10,760 |
Net income (loss) per share — Diluted | $ | 0.08 |  |  | $ | (1.11 | ) |  | $ | 0.30 |  |  | $ | (0.82 | )
Weighted average shares outstanding — Diluted | 10,885 |  |  | 10,760 |  |  | 10,813 |  |  | 10,760 |

See accompanying notes to consolidated financial statements.
4

KEY TRONIC CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)
(Unaudited, in thousands)

| Three Months Ended |  | Nine Months Ended
| March 28, 2020 |  | March 30, 2019 |  | March 28, 2020 |  | March 30, 2019
Comprehensive income (loss): |  |  |  |  |  |  |
Net income (loss) | $ | 910 |  |  | $ | (11,981 | ) |  | $ | 3,286 |  |  | $ | (8,799 | )
Other comprehensive income (loss): |  |  |  |  |  |  |
Unrealized gain (loss) on hedging instruments, net of tax | (4,836 | ) |  | 859 |  |  | (5,005 | ) |  | 3,019 |
Comprehensive income (loss) | $ | (3,926 | ) |  | $ | (11,122 | ) |  | $ | (1,719 | ) |  | $ | (5,780 | )

Other comprehensive income (loss) for the three months ended March 28, 2020 and March 30, 2019, is reflected net of tax expense (benefit) of approximately $(1.4) million and $0.2 million, respectively. Other comprehensive income (loss) for the nine months ended March 28, 2020 and March 30, 2019, is reflected net of tax expense (benefit) of approximately $(1.5) million and $0.8 million, respectively.
See accompanying notes to consolidated financial statements.
5

KEY TRONIC CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOW
(Unaudited, in thousands)

| Nine Months Ended
| March 28, 2020 |  | March 30, 2019
Operating activities: |  |  |
Net income (loss) | $ | 3,286 |  |  | $ | (8,799 | )
Adjustments to reconcile net income (loss) to cash provided by (used in) operating activities: |  |  |
Goodwill and intangible assets impairment | — |  |  | 12,448 |
Depreciation and amortization | 3,996 |  |  | 5,520 |
Amortization of deferred loan costs | 22 |  |  | 22 |
Provision for obsolete inventory | 76 |  |  | 70 |
Provision for warranty | 125 |  |  | 67 |
Provision for doubtful accounts | 551 |  |  | 58 |
Loss on disposal of assets | 207 |  |  | — |
Share-based compensation expense | 200 |  |  | 354 |
Deferred income taxes | (525 | ) |  | (936 | )
Changes in operating assets and liabilities: |  |  |
Trade receivables | (19,456 | ) |  | 5,534 |
Contract assets | 4,480 |  |  | (8,232 | )
Cash received from arbitration settlement | — |  |  | 6,684 |
Inventories | (13,697 | ) |  | 3,639 |
Other assets | (9,068 | ) |  | (3,648 | )
Accounts payable | (1,679 | ) |  | (7,439 | )
Accrued compensation and vacation | (57 | ) |  | (1,769 | )
Other liabilities | (522 | ) |  | (185 | )
Cash (used in) provided by operating activities | (32,061 | ) |  | 3,388 |
Investing activities: |  |  |
Purchase of property and equipment | (5,921 | ) |  | (5,841 | )
Proceeds from sale of fixed assets | 696 |  |  | 17 |
Cash receipts from deferred purchase price of factored receivables | 4,350 |  |  | 4,768 |
Cash used in investing activities | (875 | ) |  | (1,056 | )
Financing activities: |  |  |
Payment of financing costs | (7 | ) |  | (11 | )
Proceeds from issuance of long term debt | 5,000 |  |  | — |
Repayments of long term debt | (5,236 | ) |  | (4,403 | )
Borrowings under revolving credit agreement | 148,303 |  |  | 140,047 |
Repayments of revolving credit agreement | (114,423 | ) |  | (138,143 | )
Cash provided by (used in) financing activities | 33,637 |  |  | (2,510 | )
Net increase (decrease) in cash and cash equivalents | 701 |  |  | (178 | )
Cash and cash equivalents, beginning of period | 601 |  |  | 343 |
Cash and cash equivalents, end of period | $ | 1,302 |  |  | $ | 165 |
Non-cash investing activities: |  |  |
Beneficial interest in transferred receivables | (5 | ) |  | (2,083 | )
Supplemental cash flow information: |  |  |
Interest payments | $ | 1,990 |  |  | $ | 2,108 |
Income tax payments (refunds), net of refunds | $ | 426 |  |  | $ | (384 | )

See accompanying notes to consolidated financial statements.
6

KEY TRONIC CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY
(Unaudited, in thousands; except share data)

|  | Three Months Ended |  | Nine Months Ended
|  | March 28, 2020 |  | March 30, 2019 |  | March 28, 2020 |  | March 30, 2019
Total shareholders’ equity, beginning balances |  | $ | 116,808 |  |  | $ | 124,226 |  |  | $ | 114,459 |  |  | $ | 118,081 |
Common stock (shares): |  |  |  |  |  |  |  |
Beginning balances |  | $ | 10,760 |  |  | $ | 10,760 |  |  | $ | 10,760 |  |  | $ | 10,760 |
Exercise of stock appreciation rights |  | — |  |  | — |  |  | — |  |  | — |
Ending balances |  | 10,760 |  |  | 10,760 |  |  | 10,760 |  |  | 10,760 |
Common stock: |  |  |  |  |  |  |  |
Beginning balances |  | $ | 46,821 |  |  | $ | 46,518 |  |  | $ | 46,680 |  |  | $ | 46,244 |
Share-based compensation |  | 59 |  |  | 80 |  |  | 200 |  |  | 354 |
Ending balances |  | 46,880 |  |  | 46,598 |  |  | 46,880 |  |  | 46,598 |
Retained Earnings: |  |  |  |  |  |  |  |
Beginning balances |  | $ | 67,729 |  |  | $ | 76,517 |  |  | $ | 65,353 |  |  | $ | 72,806 |
Net income |  | 910 |  |  | (11,981 | ) |  | 3,286 |  |  | (8,799 | )
ASC 606 opening balance sheet adjustment |  | — |  |  | — |  |  | — |  |  | 529 |
Ending balances |  | 68,639 |  |  | 64,536 |  |  | 68,639 |  |  | 64,536 |
Accumulated other comprehensive income: |  |  |  |  |  |  |  |
Beginning balances |  | $ | 2,257 |  |  | $ | 1,191 |  |  | $ | 2,426 |  |  | $ | (969 | )
Unrealized gain (loss) on hedging instruments, net |  | (4,836 | ) |  | 859 |  |  | (5,005 | ) |  | 3,019 |
Ending balances |  | (2,579 | ) |  | 2,050 |  |  | (2,579 | ) |  | 2,050 |
Total shareholder’s equity, ending balances |  | $ | 112,940 |  |  | $ | 113,184 |  |  | $ | 112,940 |  |  | $ | 113,184 |

See accompanying notes to consolidated financial statements.
7

KEY TRONIC CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)

1. | Basis of Presentation

The consolidated financial statements included herein have been prepared by Key Tronic Corporation and subsidiaries (the Company) pursuant to the rules and regulations of the Securities and Exchange Commission (SEC). Certain information and footnote disclosures normally included in our annual consolidated financial statements have been condensed or omitted. The year-end condensed consolidated balance sheet information was derived from audited financial statements, but does not include all disclosures required by accounting principles generally accepted in the United States of America. The financial statements reflect all normal and recurring adjustments which, in the opinion of management, are necessary for a fair presentation of the financial position, results of operations and cash flows for the interim periods presented. The preparation of financial statements in accordance with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the reported amounts of revenues and expenses during the reporting period. The results of operations for the periods presented are not necessarily indicative of the results to be expected for the full year. The accompanying unaudited condensed consolidated financial statements should be read in conjunction with the financial statements and notes included in the Company’s Annual Report on Form 10-K for the fiscal year ended June 29, 2019.
The Company’s reporting period is a 52/53 week fiscal year ending on the Saturday closest to June 30. The three and nine month periods ended March 28, 2020 and March 30, 2019, were 13 and 39 week periods, respectively. Fiscal year 2020 will end on June 27, 2020, which is a 52 week year. Fiscal year 2019 which ended on June 29, 2019, was also a 52 week year.
The 2019 novel strain of coronavirus ("COVID-19") has resulted in business slowdowns or shutdowns in affected areas. In January 2020, the Company’s China facilities faced temporary shutdowns as a result of government mandates. In March 2020, these facilities began returning to full operation and the supply chain disruptions have been abating. In April 2020, the Company announced the temporary closure of its Juarez facilities, however, operations successfully resumed six days later.
Due to the COVID-19 pandemic, the Company has seen extreme shifts in demand from its customer base. The possibility of future temporary closures, as well as adverse fluctuations in customer demand, freight and expedite costs, precautionary safety expenses, collectibility of accounts, and future supply chain disruptions during the rapidly changing COVID-19 environment can materially impact operating results. Additionally, continued adverse macroeconomic conditions and significant currency exchange fluctuations can also materially impact operating results.

2. | Significant Accounting Policies

Earnings Per Common Share
Basic earnings per common share (EPS) is computed by dividing net income (loss) by the weighted average number of common shares outstanding during the period. Diluted EPS is computed by dividing net income (loss) by the combination of other potentially dilutive weighted average common shares and the weighted average number of common shares outstanding during the period using the treasury stock method. The computation assumes the proceeds from the exercise of equity awards were used to repurchase common shares at the average market price during the period. The computation of diluted EPS does not assume conversion, exercise, or contingent issuance of common stock equivalent shares that would have an anti-dilutive effect on EPS.
Derivative Instruments and Hedging Activities
The Company has entered into foreign currency forward contracts, foreign currency swaps and an interest rate swap which are accounted for as cash flow hedges in accordance with ASC 815, “Derivatives and Hedging”. The effective portion of the gain or loss on the derivative is reported as a component of accumulated other comprehensive income (AOCI) and is reclassified into earnings in the same period in which the underlying hedged transaction affects earnings. The derivative’s effectiveness represents the change in fair value of the hedge that offsets the change in fair value of the hedged item.
The Company uses derivatives to manage the variability of foreign currency fluctuations of expenses in our Mexico facilities and interest rate risk associated with certain borrowings under the Company’s term loan arrangement. The foreign currency forward contracts, foreign currency swaps and interest rate swap have terms that are matched to the underlying transactions being hedged. As a result, these transactions fully offset the hedged risk and no ineffectiveness has been recorded.
8

The Company’s foreign currency forward contracts, and interest rate swap potentially expose the Company to credit risk to the extent the counterparty may be unable to meet the terms of the agreement. The Company minimizes such risk by utilizing a counterparty with a strong credit rating. The Company’s counterparty to the foreign currency forward contracts, foreign currency swaps and interest rate swap is a major banking institution. This institution does not require collateral for the contracts, and the Company believes that the risk of the counterparty failing to meet their contractual obligations is remote. The Company does not enter into derivative instruments for trading or speculative purposes.
Income Taxes
We compute our interim income tax provision through the use of an estimated annual effective tax rate (ETR) applied to year-to-date operating results and specific events that are discretely recognized as they occur. In determining the estimated annual ETR, we analyze various factors, including projections of our annual earnings, taxing jurisdictions in which the earnings will be generated, the impact of state and local income taxes, our ability to use tax credits and available tax planning alternatives. Discrete items, including the effect of changes in tax laws, tax rates, and certain circumstances with respect to valuation allowances or other unusual or non-recurring tax adjustments, are reflected in the period in which they occur as an addition to, or reduction from, the income tax provision, rather than included in the estimated annual ETR.
Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the estimated future tax consequences and benefits attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases, as well as tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which temporary differences and carryforwards are expected to be recovered or settled. The effect on deferred tax assets and liabilities for a change in tax rates is recognized in the period that includes the enactment date. Valuation allowances are established when necessary to reduce deferred tax assets to the amount that is more likely than not to be realized.
We utilize a two-step approach to recognizing and measuring uncertain tax positions. The first step is to evaluate the tax position for recognition by determining if the weight of available evidence indicates it is more likely than not that the position will be sustained on audit, including resolution of related appeals or litigation processes, if any. The second step is to measure the tax benefit as the largest amount which is more than 50% likely of being realized upon ultimate settlement. We consider many factors when evaluating and estimating our tax positions and tax benefits, which may require periodic adjustments based on new assessments and changes in estimates and which may not accurately forecast actual outcomes. Our policy is to recognize interest and penalties related to the underpayment of income taxes as a component of income tax expense. The tax years 1998 through the present remain open to examination by the major U.S. taxing jurisdictions to which we are subject. Refer to Note 6 for further discussions.
Impairment of Goodwill and Other Intangible Assets
The Company records intangible assets that are acquired individually or with a group of other assets in the financial statements at acquisition. In accordance with ASC 350, Goodwill and Other Intangible Assets, goodwill and intangible assets acquired in a business combination and determined to have an indefinite useful life are not amortized but are required to be reviewed for impairment at least annually or when events or circumstances indicate that carrying value may exceed fair value. The Company’s acquired intangible assets are subject to amortization over their estimated useful lives and are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an intangible asset may not be recoverable. Refer to footnote 12 for recognition of intangible asset in accordance with ASC 842.
Recently Issued Accounting Standards
In March of 2020, the FASB issued ASU 2020-03, Codification Improvements to Financial Instruments, which clarifies specific issues raised by stakeholders. Specifically, the ASU clarifies the following: 1) that all entities are required to provide the fair value option disclosures in ASC 825, Financial Instruments 2) clarifies that the portfolio exception in ASC 820, Fair Value Measurement, applies to nonfinancial items accounted for as derivatives under ASC 815, Derivatives and Hedging; 3) clarifies that for purposes of measuring expected credit losses on a net investment in a lease in accordance with ASC 326, Financial Instruments - Credit Losses, the lease term determined in accordance with ASC 842, Leases, should be used as the contractual term; 4) clarifies that when an entity regains control of financial assets sold, it should recognize an allowance for credit losses in accordance with ASC 326; and 5) aligns the disclosure requirements for debt securities in ASC 320, Investments - Debt Securities, with the corresponding requirements for depository and lending institutions in ASC 942, Financial Services - Depository and Lending. The amendments in the ASU have various effective dates and transition requirements which are dependent on timing of adoption of ASU 2016-13. The Company is currently assessing the effects on its consolidated financial statements, and it intends to adopt the guidance as they become effective.
9

In December 2019, the FASB issued ASU 2019-12, Simplifying the Accounting for Income Taxes (Topic 740), which modifies certain provisions of ASC 740, Income Taxes, in an effort to reduce the complexity of accounting for income taxes. ASU 2019-12 is effective for us the first quarter of fiscal year 2022. We are currently evaluating the effects and do not believe this standard will have a material impact on our consolidated financial position, results of operations, or cash flows.
In February 2016, the FASB issued Accounting Standards Update ASC 2016-02, Leases which supersedes ASC 840 Leases and creates a new topic, ASC 842 Leases. This update requires lessees to recognize a lease asset and a lease liability for all leases, including operating leases, with a term greater than 12 months on its balance sheet. The update also expands the required quantitative and qualitative disclosures surrounding leases. In July 2018, the FASB issued Accounting Standards Update 2018-10, Codification Improvements to Topic 842, Leases. The update is intended to clarify certain aspects of the new lease standard, Topic 842. The amendments affect narrow aspects of the guidance issued in update 2016-02 discussed above. The amendments address residual value guarantees, the rate implicit in the lease, certain lessee and lessor reassessments, variable lease payments that depend on an index or rate, investment tax credits, lease term and purchase option, transition guidance and certain adjustments, impairment of the net investment in the lease, residual assets that are not guaranteed, as well as other areas of improvement and clarification. The amendments have the same effective date and transition requirements as the new lease standard.
The Company adopted ASC 842 on June 30, 2019 using the modified retrospective method for leases existing at, or entered into after, June 30, 2019. As a result, the Company was not required to adjust its comparative period financial information for effects of the standard or make the new required lease disclosures for periods before our adoption date. Management elected the package of practical expedients which, among other things, allows the Company to carry forward historical lease classification in place prior to June 30, 2019. ASC 842 also provides practical expedients for an entity’s accounting after transition. Management has elected the short-term lease recognition exemption for all leases that qualify, as well as the practical expedient to not separate lease and non-lease components. Both of these expedients were elected for all classes of underlying leased assets. As the Company cannot determine the interest rate implicit in the lease for its leases, the Company uses its estimate of the incremental borrowing rate as of the commencement date in determining the present value of lease payments. The Company’s estimated incremental borrowing rate is the rate of interest it would have to pay on a collateralized basis over a similar term in an amount equal to the lease payments in a similar economic environment. The lease term for all of the Company’s leases includes the noncancellable period of the lease plus any additional periods covered by either an option to extend (or not to terminate) the lease that the Company is reasonably certain to exercise.
The adoption of ASC 842 had a material impact to the Company’s consolidated balance sheet, but did not materially impact the consolidated statement of income or consolidated statement of cash flows. The most significant changes to the consolidated balance sheet relate to the recognition of new right-of-use (ROU) assets and lease liabilities for operating leases.
As a result of adopting ASC 842 as of June 30, 2019, the Company recognized an ROU asset of $17.2 million, a corresponding lease liability of $16.2 million, a reduction in prepaid rent of $0.4 million, a reduction of favorable lease agreement intangible of $0.7 million, and no adjustment to retained earnings or future P&L impact.
In June 2016, the FASB issued ASU 2016-13 “Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments” and also issued subsequent amendments to the initial guidance: ASU 2018-19, ASU 2019-04 and ASU 2019-05, which replaces the existing incurred loss impairment model with an expected credit loss model and requires a financial asset measured at amortized cost to be presented at the net amount expected to be collected. The guidance is effective for the Company beginning in the first quarter of fiscal year 2024 with early adoption permitted. The Company is currently assessing the impact on its consolidated financial statements, and it intends to adopt the guidance when it becomes effective in the first quarter of fiscal year 2024.

3. | Inventories

The components of inventories consist of the following (in thousands):

| March 28, 2020 |  | June 29, 2019
Finished goods | $ | 15,390 |  |  | $ | 11,969 |
Work-in-process | 19,346 |  |  | 11,705 |
Raw materials and supplies | 79,316 |  |  | 76,757 |
| $ | 114,052 |  |  | $ | 100,431 |

Total inventory as of March 28, 2020 is net of $13.5 million of reserves, customer payments, and customer deposits compared to $10.0 million in reserves, customer payments, and customer deposits as of June 29, 2019.
10

4. | Long-Term Debt

On March 5, 2020, the Company entered into a Seventh amendment to the amended and restated credit agreement extending the limit on our line of credit facility to $65.0 million. Outside of the limit increase of the credit facility, the agreement reflects the same specifications and terms as the sixth amendment to the amended and restated credit agreement entered into by the Company on November 20, 2019; discussed below. As of March 28, 2020, the Company had an outstanding balance under the credit facility of $57.2 million, $0.4 million in outstanding letters of credit and $7.4 million available for future borrowings. As of June 29, 2019, the Company had an outstanding balance under the credit facility of $23.4 million, $0.4 million in outstanding letters of credit and $21.3 million available for future borrowings.
On November 20, 2019, the Company entered into a Sixth amendment to the amended and restated credit agreement extending the limit on our line of credit facility to $55.0 million as evidenced by the Second Replacement Revolving Note. The agreement specifies that the proceeds of the revolving line of credit be used primarily for working capital and general corporate purposes. The line of credit is secured by substantially all of the assets of the Company. On September 30, 2018, the Company entered into a Fourth amendment to the amended and restated credit agreement to extend the maturity date to November 1, 2023, at which time all outstanding balances are payable.
On September 10, 2019, the Company entered into a Fifth amendment to the amended and restated credit agreement to increase the outstanding balance on the term loan in the amount of $5.0 million and to extend the maturity date to September 30, 2022 on the original term loan in the amount of $35.0 million that was used to acquire all of the outstanding shares of CDR Manufacturing, Inc. (dba Ayrshire Electronics). The term loan requires quarterly payments of $1.67 million commencing December 31, 2019 through September 30, 2021, and quarterly payments of $0.4 million commencing December 31, 2021 through September 30, 2022, with a final payment of the remaining outstanding balance on September 30, 2022. The Company had an outstanding balance of $11.7 million and $11.3 million under the term loan as of March 28, 2020 and June 29, 2019, respectively.
On December 28, 2016, the Company entered into an equipment term loan agreement in the amount of $3.9 million in order to further invest in production equipment. The equipment term loan is collateralized by production equipment. Under this loan agreement, equal quarterly payments of approximately $0.2 million commenced on March 31, 2017 and will continue through the maturity of the equipment term loan on June 30, 2021. Amortization of the debt issuance costs is reported as interest expense on the consolidated income statement. As of March 28, 2020, the Company had an outstanding balance of $1.1 million. As of June 29, 2019, the Company had an outstanding balance of $1.7 million.
The Fifth amendment to the amended and restated credit agreement noted above to increase the outstanding balance on the term loan in the amount of $5.0 million fixes borrowings under the revolving line of credit, term loan and equipment term loan to bear interest at LIBOR plus 2.0%, as opposed to previous borrowings at either a “Base Rate” or a “Fixed Rate,” as elected by the Company. The base rate is the higher of the Wells Fargo Bank prime rate, daily one month London Interbank Offered Rate (LIBOR) plus 1.5%, or the Federal Funds rate plus 1.5%. The fixed rate is LIBOR plus 1.75%, LIBOR plus 2.00%, or LIBOR plus 2.25% depending on the level of the Company’s trailing four quarters Earnings Before Interest, Taxes, Depreciation and Amortization (EBITDA). The interest rates on outstanding debt as of March 28, 2020 range from 2.99% - 3.58% compared to 4.40% - 5.50% as of June 29, 2019.
Debt maturities as of March 28, 2020 for the next five years and thereafter are as follows (in thousands):

Fiscal Years Ending | Amount
2020 (1) | $ | 1,884 |
2021 | 7,537 |
2022 | 2,917 |
2023 | 417 |
2024 | 57,236 |
Total debt | $ | 69,991 |
Unamortized debt issuance costs | (37 | )
Long-term debt, net of debt issuance costs | $ | 69,954 |

(1) Represents scheduled payments for the remaining three-month period ending June 27, 2020.
The Company must comply with certain financial covenants, including a fixed charge coverage ratio. The credit agreement requires the Company to maintain a minimum profit threshold, limits the maximum capital lease expenditures and restricts the Company from declaring or paying dividends in cash or stock without prior bank approval. The Company was in compliance with all financial covenants as of March 28, 2020.
11

5. | Trade Accounts Receivable Purchase Programs

Sale Programs
The Company has utilized an Account Purchase Agreement with Wells Fargo Bank, N.A. (“WFB”) which allows the Company to sell and assign to WFB and WFB may purchase from the Company the accounts receivable of certain Company customers in a maximum aggregate amount outstanding of $25.0 million. As of March 28, 2020, the Company has no factored receivables with WFB. The Company also has an Account Purchase Agreement with Orbian Financial Services (“Orbian”). This agreement allows the Company to sell accounts receivable of certain customers to Orbian and the agreement may be cancelled at any time by either party.
Total accounts receivables sold during the nine months ended March 28, 2020 and March 30, 2019 was approximately $38.6 million and $62.0 million, respectively. Accounts receivables sold and not yet collected were $5,000 and $1.7 million as of March 28, 2020 and June 29, 2019, respectively. The receivables that were sold were removed from the condensed consolidated balance sheets and the cash received is reflected as cash provided by operating activities in the condensed consolidated statements of cash flows. Cash receipts related to the deferred purchase price from receivables factored by the Company is reflected as cash provided by investing activities.

6. | Income Taxes

On December 22, 2017, the Tax Cuts and Jobs Act (“Tax Act”) was signed into law. The Tax Act reduced Federal corporate tax rates effective January 1, 2018 and changed certain other provisions, many of which were not effective until fiscal year 2019.
As a result of the change of the U.S. tax system under the Tax Act from a global to a territorial model, a deemed one-time repatriation of all accumulated earnings and profits (AE&P) in Mexico and China occurred on December 31, 2017 (the “Transition Tax”).
On December 22, 2017, the staff of the SEC issued Staff Accounting Bulletin No. 118 (“SAB No. 118”). SAB No. 118 provides guidance on accounting for the tax effects of the 2017 Tax Act and allows registrants to record provisional amounts for a period of up to one year from the date of enactment of the 2017 Tax Act. In fiscal year 2019 we finalized the effects of the Tax Act, resulting in a net Transition Tax amount of $0.8 million, a decrease of $0.4 million compared to the amount provisioned in fiscal year 2018.
In future years, because of the Transition Tax on AE&P described above, repatriations of cash will generally be tax-free in the U.S. However, withholding taxes in China may still apply to any such future repatriations. Management has not changed its indefinite investment assertions with regard to the portion of AE&P in China that may be repatriated in the future. Accordingly, management estimates that future repatriations of cash from China may result in approximately $0.8 million of withholding tax. There would be no offsetting foreign tax credits in the U.S. and as such, this potential liability is a direct cost associated with actual repatriations. Withholding taxes will not apply to future repatriations from Mexico or Vietnam.
The Company expects to repatriate a portion of its foreign earnings based on increased net sales growth driving additional capital requirements domestically, cash requirements for potential acquisitions and to implement certain tax strategies. The Company currently expects to repatriate approximately $7.7 million of foreign earnings in the future. All other unremitted foreign earnings are expected to remain permanently reinvested for planned fixed assets purchases and improvements in foreign locations.
The Company has available approximately $9.7 million of gross federal research and development tax credits as of March 28, 2020. ASC 740 requires the Company to recognize in its financial statements uncertainties in tax positions taken that may not be sustained upon examination by the taxing authorities. Accordingly, as of March 28, 2020, the Company has recorded $4.2 million of unrecognized tax benefits associated with these federal tax credits, resulting in a net deferred tax benefit of approximately $5.5 million.
12

On March 27, 2020, the Coronavirus Aid, Relief, and Economic Security Act (CARES Act) was enacted in response to the COVID-19 pandemic. The CARES Act, among other things, permits net operating loss (NOL) carryovers and carrybacks to offset 100% of taxable income for taxable years beginning before 2021. In addition, the CARES Act allows NOLs incurred in 2018, 2019, and 2020 to be carried back to each of the five preceding taxable years to generate a refund of previously paid income taxes. The Company does not expect that the NOL carryback provision of the CARES Act will result in a material cash benefit. In addition, the CARES Act contains modifications on the limitation of business interest for tax years beginning in 2019 and 2020. The modifications to Section 163(j) increase the allowable business interest deduction from 30% of adjusted taxable income to 50% of adjusted taxable income. This modification would increase the allowable interest expense deduction of the Company and result in less taxable income for fiscal year 2020, but is not expected to have a material impact on the provision for income taxes. Also, under the CARES Act, AMT credits not previously refunded for the 2018 tax year are refundable in the 2019 taxable year rather than in years 2019-2021, and taxpayers can elect to claim 100% of the AMT credits in the first taxable year beginning in 2018 by applying for a tentative refund claim on or before December 31, 2020. The Company has made this election by applying for a tentative refund claim. The Company is continuing to evaluate the impacts of other aspects of the CARES Act, and at this time the Company does not believe they will have a material impact on our consolidated financial position, results of operations, or cash flows.

7. | Earnings Per Share

The following tables present a reconciliation of the denominator in the basic and diluted EPS calculation and the number of antidilutive common share awards that were not included in the diluted earnings per share calculation. These antidilutive securities occur when equity awards outstanding have an option price greater than the average market price for the period.

| Three Months Ended
| (in thousands, except share and per share information)
| March 28, 2020 |  | March 30, 2019
Net income (loss) | $ | 910 |  |  | $ | (11,981 | )
Weighted average shares outstanding—basic | 10,760 |  |  | 10,760 |
Effect of dilutive common stock awards | 125 |  |  | — |
Weighted average shares outstanding—diluted | 10,885 |  |  | 10,760 |
Net income (loss) per share—basic | $ | 0.08 |  |  | $ | (1.11 | )
Net income (loss) per share—diluted | $ | 0.08 |  |  | $ | (1.11 | )
Antidilutive SARs not included in diluted earnings per share | 720 |  |  | 1,005 |

| Nine Months Ended
| (in thousands, except share and per share information)
| March 28, 2020 |  | March 30, 2019
Net income (loss) | $ | 3,286 |  |  | $ | (8,799 | )
Weighted average shares outstanding—basic | 10,760 |  |  | 10,760 |
Effect of dilutive common stock awards | 53 |  |  | — |
Weighted average shares outstanding—diluted | 10,813 |  |  | 10,760 |
Net income (loss) per share—basic | $ | 0.31 |  |  | $ | (0.82 | )
Net income (loss) per share—diluted | $ | 0.30 |  |  | $ | (0.82 | )
Antidilutive SARs not included in diluted earnings per share | 720 |  |  | 1,005 |

8. Share-based Compensation
The Company’s incentive plan provides for equity and liability awards to employees and non-employee directors in the form of stock options, stock appreciation rights (SARs), restricted stock, restricted stock units, stock awards, stock units, performance shares, performance units, and other stock-based or cash-based awards. Compensation cost is recognized on a straight-line basis over the requisite employee service period, which is generally the vesting period, and is recorded as employee compensation expense in cost of goods sold, research, development and engineering, and selling, general and administrative expenses. Share-based compensation is recognized only for those awards that are expected to vest, with forfeitures estimated at the date of grant based on historical experience and future expectations.
13

In addition to service conditions, SARs contain a performance condition. The additional performance condition is based upon the achievement of Return on Invested Capital (ROIC) goals relative to a peer group. All awards with performance conditions are evaluated quarterly to determine the likelihood that performance metrics will be achieved during the performance period. These awards are charged to compensation expense over the requisite service period based on the number of shares expected to vest. The SARs cliff vest after a three-year period from date of grant and expire five years from date of grant.
The grant date fair value for the awards granted below were estimated using the Black Scholes option valuation method:

| July 26, 2019 |  | July 27, 2018
SARs Granted | 170,000 |  |  | 161,250 |
Strike Price | $ | 4.93 |  |  | $ | 8.17 |
Fair Value | $ | 1.23 |  |  | $ | 2.27 |

Total share-based compensation expense recognized during the three months ended March 28, 2020 and March 30, 2019 was approximately $59,000 and $80,000, respectively. Total share-based compensation expense recognized during the nine months ended March 28, 2020 and March 30, 2019 was approximately $200,000 and $354,000, respectively.
As of March 28, 2020, total unrecognized compensation expense related to unvested share-based compensation arrangements was approximately $0.3 million. This expense is expected to be recognized over a weighted average period of 1.65 years. No SARs were exercised during the three or nine months ended March 28, 2020 or March 30, 2019.

9. | Commitments and Contingencies

Litigation and Other Matters
The Company is party to certain lawsuits or claims in the ordinary course of business. The Company does not believe that these proceedings, individually or in the aggregate, will have a material adverse effect on the financial position, results of operations or cash flow of the Company.
Warranties
The Company provides warranties on certain product sales. Allowances for estimated warranty costs are recorded during the period of sale. The determination of such allowances requires the Company to make estimates of product return rates and expected costs to repair or to replace the products under warranty. If actual return rates and/or repair and replacement costs differ significantly from management’s estimates, adjustments to recognize additional cost of sales may be required in future periods. The Company’s warranty reserve was approximately $33,000 as of March 28, 2020 and $22,000 as of June 29, 2019, respectively.

10. | Derivative Financial Instruments

As of March 28, 2020, the Company had outstanding foreign currency forward contracts with a total notional amount of $43.0 million. The maturity dates for these contracts extend through December 2021. For the three months ended March 28, 2020, the Company entered into $23.8 million of foreign currency forward contracts and settled $6.6 million of such contracts. During the same period of the previous year, the Company did not enter into any foreign currency forward contracts and settled $7.0 million of such contracts.
For the nine months ended March 28, 2020, the Company entered into $23.8 million of foreign currency forward contracts and settled $20.5 million of such contracts. During the same period of the previous year, the Company entered into foreign currency forward contracts of $6.3 million and settled $19.0 million of such contracts.
As of March 28, 2020, the aggregate notional amount of the Company’s outstanding foreign currency contracts along with their unrealized gains (losses) are expected to mature as summarized below (in thousands):

Quarter Ending |  | Notional Contracts in MXN |  | Notional Contracts in USD |  | Estimated Fair Value
June 27, 2020 |  | $ | 138,213 |  |  | $ | 6,257 |  |  | $ | (365 | )
September 26, 2020 |  | $ | 141,173 |  |  | $ | 6,729 |  |  | $ | (790 | )
December 26, 2020 |  | $ | 132,773 |  |  | $ | 6,241 |  |  | $ | (725 | )
April 3, 2021 |  | $ | 148,253 |  |  | $ | 6,682 |  |  | $ | (598 | )
July 3, 2021 |  | $ | 144,725 |  |  | $ | 6,446 |  |  | $ | (576 | )
October 2, 2021 |  | $ | 146,373 |  |  | $ | 5,502 |  |  | $ | 360 |
January 1, 2022 |  | $ | 137,973 |  |  | $ | 5,129 |  |  | $ | 328 |

14

On November 6, 2019, the Company entered into an interest rate swap contract with an effective date of November 6, 2019 and a termination date of September 30, 2022, related to the borrowings outstanding under the term loan. This interest rate swap pays the Company variable interest at the one month LIBOR rate, and the Company pays the counter party a fixed interest rate. The fixed interest rate for the contract is 1.70% that replaces the one month LIBOR rate component of our contractual interest to be paid to WFB as part of our term loan. Based on the terms of the interest rate swap contract and the underlying borrowings outstanding under the term loan, the interest rate contract was determined to be effective, and thus qualified as a cash flow hedge.
On November 6, 2019, the Company entered into an interest rate swap contract with an effective date of November 6, 2019 and a termination date of November 1, 2023, related to the borrowings outstanding under the line of credit. This interest rate swap pays the Company variable interest at the one month LIBOR rate, and the Company pays the counter party a fixed interest rate. The fixed interest rate for the contract is 1.67% that replaces the one month LIBOR rate component of our contractual interest to be paid to WFB as part of our line of credit. Based on the terms of the interest rate swap contract and the underlying borrowings outstanding under the line of credit, the interest rate contract was determined to be effective, and thus qualified as a cash flow hedge.
The following table summarizes the fair value of derivative instruments in the Consolidated Balance Sheet as of March 28, 2020 and June 29, 2019 (in thousands):

|  |  | March 28, 2020 |  | June 29, 2019
Derivatives Designated as Hedging Instruments | Balance Sheet Location |  | Fair Value |  | Fair Value
Foreign currency forward contracts & swaps | Other current assets |  | $ | — |  |  | $ | 2,912 |
Foreign currency forward contracts & swaps | Other long-term assets |  | $ | 687 |  |  | $ | 320 |
Foreign currency forward contracts & swaps | Other current liabilities |  | $ | (2,478 | ) |  | $ | — |
Foreign currency forward contracts & swaps | Other long-term liabilities |  | $ | (576 | ) |  | $ | — |
Interest rate swap | Other current assets |  | $ | 3 |  |  | $ | 2 |
Interest rate swap | Other current liabilities |  | $ | (326 | ) |  | $ | — |
Interest rate swap | Other long-term liabilities |  | $ | (541 | ) |  | $ | — |

The following tables summarize the gain (loss) on derivative instruments, net of tax, on the Consolidated Statements of Income for the three months ended March 28, 2020 and March 30, 2019, respectively (in thousands):

Derivatives Designated as Hedging Instruments | Classification of Gain (Loss) Reclassified from Accumulated OCI into Income (Effective Portion) |  | AOCI Balance as of December 28, 2019 |  | Effective Portion Recorded In AOCI |  | Effective Portion Reclassified From AOCI Into Income |  | AOCI Balance as of March 28, 2020
Forward contracts & swaps | Cost of sales |  | $ | 2,329 |  |  | $ | (3,163 | ) |  | $ | (1,077 | ) |  | $ | (1,911 | )
Interest rate swap | Interest expense |  | (72 | ) |  | (591 | ) |  | (5 | ) |  | (668 | )
Total |  |  | $ | 2,257 |  |  | $ | (3,754 | ) |  | $ | (1,082 | ) |  | $ | (2,579 | )
Derivatives Designated as Hedging Instruments | Classification of Gain (Loss) Reclassified from Accumulated OCI into Income (Effective Portion) |  | AOCI Balance as of December 29, 2018 |  | Effective Portion Recorded In AOCI |  | Effective Portion Reclassified From AOCI Into Income |  | AOCI Balance as of March 30, 2019
Forward contracts & swaps | Cost of sales |  | $ | 1,178 |  |  | $ | 1,059 |  |  | $ | (194 | ) |  | $ | 2,043 |
Interest rate swap | Interest expense |  | 13 |  |  | 1 |  |  | (7 | ) |  | 7 |
Total |  |  | $ | 1,191 |  |  | $ | 1,060 |  |  | $ | (201 | ) |  | $ | 2,050 |

15

The following tables summarize the gain (loss) on derivative instruments, net of tax, on the Consolidated Statements of Income for the nine months ended March 28, 2020 and March 30, 2019, respectively (in thousands):

Derivatives Designated as Hedging Instruments | Classification of Gain (Loss) Reclassified from Accumulated OCI into Income (Effective Portion) |  | AOCI Balance as of June 29, 2019 |  | Effective Portion Recorded In AOCI |  | Effective Portion Reclassified From AOCI Into Income |  | AOCI Balance as of March 28, 2020
Forward contracts & swaps | Cost of sales |  | $ | 2,424 |  |  | $ | (1,671 | ) |  | $ | (2,664 | ) |  | $ | (1,911 | )
Interest rate swap | Interest expense |  | 2 |  |  | (662 | ) |  | (8 | ) |  | (668 | )
Total |  |  | $ | 2,426 |  |  | $ | (2,333 | ) |  | $ | (2,672 | ) |  | $ | (2,579 | )
Derivatives Designated as Hedging Instruments | Classification of Gain (Loss) Reclassified from Accumulated OCI into Income (Effective Portion) |  | AOCI Balance as of June 30, 2018 |  | Effective Portion Recorded In AOCI |  | Effective Portion Reclassified From AOCI Into Income |  | AOCI Balance as of March 30, 2019
Forward contracts & swaps | Cost of sales |  | $ | (988 | ) |  | $ | 2,308 |  |  | $ | 723 |  |  | $ | 2,043 |
Interest rate swap | Interest expense |  | 19 |  |  | 2 |  |  | (14 | ) |  | 7 |
Total |  |  | $ | (969 | ) |  | $ | 2,310 |  |  | $ | 709 |  |  | $ | 2,050 |

As of March 28, 2020, the net amount of unrealized loss expected to be reclassified into earnings within the next 12 months is approximately $2.2 million. As of March 28, 2020, the Company does not have any foreign exchange contracts with credit-risk-related contingent features.

11. | Fair Value Measurements

The Company has adopted ASC 820, Fair Value Measurements, which defines fair value, establishes a framework for assets and liabilities being measured and reported at fair value and expands disclosures about fair value measurements. There are three levels of fair value hierarchy inputs used to value assets and liabilities which include: Level 1 – inputs are quoted market prices for identical assets or liabilities; Level 2 – inputs other than quoted market prices included in Level 1 that are observable for the asset or liability, either directly or indirectly; and Level 3 – inputs are unobservable inputs for the asset or liability.
The following table summarizes the fair value of assets (liabilities) of the Company’s derivatives that are required to be measured on a recurring basis as of March 28, 2020 and June 29, 2019 (in thousands):

| March 28, 2020
| Level 1 |  | Level 2 |  | Level 3 |  | Total Fair Value
Financial Assets: |  |  |  |  |  |  |
Interest rate swaps | $ | — |  |  | $ | 3 |  |  | $ | — |  |  | $ | 3 |
Foreign currency forward contracts | $ | — |  |  | $ | 687 |  |  | $ | — |  |  | $ | 687 |
Financial Liabilities: |  |  |  |  |  |  |
Interest rate swap | $ | — |  |  | $ | (867 | ) |  | $ | — |  |  | $ | (867 | )
Foreign currency forward contracts & swaps | $ | — |  |  | $ | (3,054 | ) |  | $ | — |  |  | $ | (3,054 | )

| June 29, 2019
| Level 1 |  | Level 2 |  | Level 3 |  | Total Fair Value
Financial Assets: |  |  |  |  |  |  |
Interest rate swaps | $ | — |  |  | $ | 2 |  |  | $ | — |  |  | $ | 2 |
Foreign currency forward contracts & swaps | $ | — |  |  | $ | 3,232 |  |  | $ | — |  |  | $ | 3,232 |

16

The Company currently has forward contracts to hedge known future cash outflows for expenses denominated in the Mexican peso and an interest rate swap to mitigate risk associated with certain borrowings under the Company’s debt arrangement. These contracts are measured on a recurring basis based on the foreign currency spot rates and forward rates quoted by banks or foreign currency dealers. These contracts are marked to market using level 2 input criteria every period with the unrealized gain or loss, net of tax, reported as a component of shareholders’ equity in accumulated other comprehensive loss, as they qualify for hedge accounting.
The carrying values of cash and cash equivalents, accounts receivable and current liabilities reflected on the balance sheets at March 28, 2020 and June 29, 2019, reasonably approximate their fair value. The Company’s long-term debt, which is measured at amortized cost, primarily consists of a revolving line of credit, a term loan and an equipment term loan. These borrowings bear interest at LIBOR plus 2.0% per the Fifth amendment to the amended and restated credit agreement, as opposed to the previous interest at either a “Base Rate” or a “Fixed Rate,” as elected by the Company. Each of these rates is a variable floating rate dependent upon current market conditions and the Company’s current credit risk as discussed in footnote 4.
As a result of the determinable market rates for our revolving line of credit, term loan and equipment term loan, they are classified within Level 2 of the fair value hierarchy. Further, the carrying value of each of these instruments reasonably approximates their fair value as of March 28, 2020 and June 29, 2019.

12. | Goodwill and Other Intangible Assets

The Company recorded goodwill and intangible assets in connection with the Ayrshire and Sabre acquisitions resulting primarily in synergies that resulted from the Company's acquisitions and the assembled workforce and favorable lease agreements; respectively.
In accordance with accounting guidance on goodwill and other intangible assets, the Company evaluates goodwill for impairment at the reporting unit level annually, and whenever circumstances occur indicating that goodwill might be impaired. Upon adoption of ASU 2017-04, the Company now recognizes an impairment charge (not to exceed the total amount of goodwill allocated to the reporting unit) for the amount by which the carrying amount of a reporting unit exceeds the reporting unit’s fair value. During the third quarter of fiscal year 2019, a goodwill impairment of $10.0 million and other intangible assets impairment of $2.5 million was recognized.
In accordance with accounting guidance on goodwill and other intangible assets, the Company evaluates intangible assets for impairment at the reporting unit level annually, and whenever circumstances occur indicating that intangibles might be impaired.
During the third quarter for fiscal year 2019, the Company assessed other finite-lived intangible assets including the Company’s customer relationships and favorable lease agreements due to an indicator of possible impairment being present. As a result of the analysis performed, the Company determined that the carrying value of the customer relationships intangible asset was not recoverable and recorded an impairment for the entire carrying amount during the third quarter of fiscal year 2019. This resulted in an impairment charge related to other intangible assets of $2.5 million recognized in the third quarter of fiscal year 2019. The Company’s analysis did not indicate that any of its other long-lived assets were impaired.
During the first quarter of fiscal year 2020, the Company adopted the Accounting Standards Update 2016-02, Leases which supersedes ASC 840 Leases and creates a new topic, ASC 842 Leases. Under ASC 842, any assets or liabilities recognized in accordance with ASC 805 that are related to favorable or unfavorable terms of an operating lease for which an entity is a lessee, the entity should derecognize the asset or liability and commensurately adjust the ROU asset.
As such, the Company derecognized the intangible asset and added the offsetting amount to the ROU asset. Resulting in a reduction of favorable lease agreement intangible of $0.7 million, and no adjustment to retained earnings or future P&L impact.
17

The components of acquired intangible assets are as follows (in thousands):

| March 28, 2020
| Amortization Period in Years |  | Gross Carrying Amount |  | Accumulated Amortization |  | Impairment Recognized |  | Derecognition Favorable Lease per ASC 842 |  | Net Carrying Amount
Intangible assets: |  |  |  |  |  |  |  |  |  |  |
Favorable Lease Agreements | 4 - 7 |  | 2,941 |  |  | (2,284 | ) |  | — |  |  | (657 | ) |  | — |
Total |  |  | $ | 2,941 |  |  | $ | (2,284 | ) |  | $ | — |  |  | $ | (657 | ) |  | $ | — |

| June 29, 2019
| Amortization Period in Years |  | Gross Carrying Amount |  | Accumulated Amortization |  | Impairment Recognized |  | Net Carrying Amount
Intangible assets: |  |  |  |  |  |  |  |  |
Non-Compete Agreements | 3 - 5 |  | $ | 568 |  |  | $ | (568 | ) |  | $ | — |  |  | $ | — |
Customer Relationships | 10 |  | 4,803 |  |  | (2,311 | ) |  | (2,492 | ) |  | — |
Favorable Lease Agreements | 4 - 7 |  | 2,941 |  |  | (2,284 | ) |  | — |  |  | 657 |
Total |  |  | $ | 8,312 |  |  | $ | (5,163 | ) |  | $ | (2,492 | ) |  | $ | 657 |

Amortization expense was approximately $0 and $76,000 for the three months ended March 28, 2020 and March 30, 2019, respectively. Amortization expense was approximately $0 and $502,000 for the nine months ended March 28, 2020 and March 30, 2019, respectively.

13. | Revenue

Revenue Recognition
The Company specializes in services ranging from product manufacturing to engineering and tooling services. The first step in its process for revenue recognition is to identify the contract with a customer. A contract is defined as an agreement between two or more parties that creates enforceable rights and obligations. A contract can be written, oral, or implied. The Company generally enters into manufacturing service agreements (“MSA”) with its customers that outlines the terms of the business relationship between the customer and the Company. This includes matters such as warranty, indemnification, transfer of title and risk of loss, liability for excess and obsolete inventory, pricing, payment terms, etc. The Company will also bid on a program-by-program basis for customers in which an executed MSA may not be in place. In these instances, as well as when we have an MSA in place, we receive customer purchase orders for specific quantities and timing of products. As a result, the Company considers its contract with a customer to be the combination of the MSA and the purchase order. The transaction price is fixed and set forth in each purchase order. In the Company's normal course of business, there are no variable pricing components, or material amounts refunded to customers in the form of refunds or rebates.
The Company assesses whether control of the product or services promised under the contract is transferred to the customer at a point in time (shipment) or over time (as we manufacture the product). The Company is first required to evaluate whether its contracts meet the criteria for 'over-time' or 'point-in-time' recognition. The Company has determined that for the majority of its contracts the Company is manufacturing products for which there is no alternative use due to the unique nature of the customer-specific product, IP and other contract restrictions. The Company has an enforceable right to payment including a reasonable profit for performance completed to date with respect to these contracts. As a result, revenue is recognized under these contracts 'over-time' based on the input cost-to-cost method as it better depicts the transfer of control. This input method is based on the ratio of costs incurred to date as compared to the total estimated costs at completion of the performance obligation. For all other contracts that do not meet these criteria, such as manufacturing contracts for which the terms do not provide an enforceable right to payment for performance completed to date, the Company recognizes revenue when it has transferred control of the related manufactured products which generally occurs upon shipment to the customer. Revenue from engineering services is recognized over time as the services are performed.
The Company’s typical payment terms are 30 to 90 days and its sales arrangements do not contain any significant financing component for its customers.
The Company generally provides a warranty for workmanship on its manufacturing contracts. Historically, the amount of returns for workmanship issues has been de minimis under the Company’s warranties.
The Company elected to not disclose information about remaining performance obligations as they are part of contracts that that have expected durations of one year or less.
18

During fiscal 2020, no revenues were recognized from performance obligations satisfied or partially satisfied in previous periods.
Contract Balances
A contract asset is recognized when the Company has recognized revenue, but has not issued an invoice for payment. Contract assets are classified separately on the condensed consolidated balance sheet and transferred to receivables when the right to payment becomes unconditional. The following table summarizes the activity in the Company’s contract assets during the nine months ended March 28, 2020 (in thousands):

| Contract Assets
Beginning balance, June 29, 2019 | $ | 22,161 |
Revenue recognized | 329,192 |
Amounts collected or invoiced | (333,672 | )
Ending balance, March 28, 2020 | $ | 17,681 |

Disaggregation of Revenue
The following table presents the Company’s revenue disaggregated for the three and nine months ended March 28, 2020 (in thousands):

|  | EMS Revenue
Recognition |  | Three Months Ended |  | Nine Months Ended
|  | March 28, 2020 |  | March 30, 2019 |  | March 28, 2020 |  | March 30, 2019
Over-Time |  | $ | 110,048 |  |  | $ | 106,859 |  |  | $ | 329,192 |  |  | $ | 350,512 |
Point-in-Time |  | 1,407 |  |  | 1,095 |  |  | 4,270 |  |  | 7,951 |
Total |  | $ | 111,455 |  |  | $ | 107,954 |  |  | $ | 333,462 |  |  | $ | 358,463 |

14. | Leases

The Company has several commitments under operating leases for warehouses, manufacturing facilities, office buildings, and equipment with initial terms that expire at various dates during the next 1 year to 12 years.
The components of lease cost for the three and nine months ended March 28, 2020 were (in thousands):

Lease cost | Classification | Three-Month Period Ended |  | Nine-Month Period Ended
Operating lease cost | Cost of sales | $ | 1,162 |  |  | $ | 3,481 |
Operating lease cost | Selling, general and administrative expenses | 338 |  |  | 935 |
Total lease cost |  | $ | 1,500 |  |  | $ | 4,416 |

19

Amounts reported in the Consolidated Balance Sheet as of March 28, 2020 were (in thousands, except weighted average lease term and discount rate):

|  | March 28, 2020
Operating Leases: |  |
Operating lease right of use assets |  | $ | 15,347 |
Operating lease liabilities (1) |  | 14,875 |
Weighted-average remaining lease term (in years) |  |
Operating leases |  | 6.24 |
Weighted-average discount rate |  |
Operating leases |  | 4.1 | %

(1) The current portion of the total operating lease liabilities of $4.5 million is classified under Other Current Liabilities, resulting in $10.4 million classified under Operating Lease Liabilities in the Long-term Liabilities section of the condensed consolidated balance sheet.
Other information related to leases was as follows (in thousands):

|  | Three-Month Period Ended |  | Nine-Month Period Ended
|  | March 28, 2020
Cash paid for amounts included in the measurement of lease liabilities: |  |  |  |
Operating cash flows from operating leases |  | $ | 1,030 |  |  | $ | 3,331 |

Future lease payments under non-cancellable leases as of March 28, 2020 are as follows (in thousands):

Fiscal Years Ending |  | Operating Leases
2020 (1) |  | $ | 1,255 |
2021 |  | 4,249 |
2022 |  | 3,371 |
2023 |  | 2,597 |
2024 |  | 1,595 |
Thereafter |  | 6,337 |
Total undiscounted lease payments |  | 19,404 |
Less: present value discount |  | 4,529 |
Total lease liabilities |  | $ | 14,875 |

(1) Represents estimated lease payments for the remaining three-month period ending June 27, 2020.
20

As previously disclosed in our Annual Report on Form 10-K for the fiscal year ended June 29, 2019 and under the previous lease accounting standard ASC 840, the aggregate future minimum payments under non-cancellable operating leases, as of June 29, 2019, are as follows (in thousands):

Fiscal Years Ending |  | Operating Leases
2020 |  | $ | 4,777 |
2021 |  | 3,563 |
2022 |  | 2,641 |
2023 |  | 1,866 |
2024 |  | 1,271 |
Thereafter |  | 4,121 |
Total minimum lease payments |  | $ | 18,239 |

Management’s Discussion and Analysis of Financial Condition and Results of Operations
FORWARD-LOOKING STATEMENTS
References in this report to “the Company,” “Key Tronic,” “KeyTronicEMS,” “we,” “our,” or “us” mean Key Tronic Corporation together with its subsidiaries, except where the context otherwise requires.
This Quarterly Report contains forward-looking statements in addition to historical information. Forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those reflected in the forward-looking statements. Risks and uncertainties that might cause such differences include, but are not limited to those outlined in “Management’s Discussion and Analysis of Financial Condition and Results of Operations—Risks and Uncertainties that May Affect Future Results.” Readers are cautioned not to place undue reliance on forward-looking statements, which reflect management’s opinions only as of the date hereof. The Company undertakes no obligation to update forward-looking statements to reflect developments or information obtained after the date hereof and disclaims any obligation to do so. Readers should carefully review the risk factors described in periodic reports the Company files from time to time with the Securities and Exchange Commission, including Year-end Reports on Form 10-K, Quarterly Reports on Form 10-Q and Current Reports on Form 8-K.
Overview
KeyTronicEMS is a leader in electronic manufacturing services (EMS) and solutions to original equipment manufacturers of a broad range of products including consumer products, communications, medical, defense, automotive, electronics, gaming, industrial and computer markets. We provide engineering services, worldwide procurement and distribution, materials management, world-class manufacturing and assembly services, in-house testing, and unparalleled customer service. Our combined capabilities and vertical integration are proving to be a desirable offering to our expanded customer base.
Our international production capability provides our customers with benefits of improved supply-chain management, reduced inventories, lower transportation costs, and reduced product fulfillment time. We continue to make investments in all of our operating facilities to give us the production capacity, capabilities and logistical advantages to continue to win new business. The following information should be read in conjunction with the consolidated financial statements included herein and with Part II Item 1A, Risk Factors included as part of this filing.
Our mission is to provide our customers with superior manufacturing and engineering services at the lowest total cost for the highest quality products, and create long-term mutually beneficial business relationships by employing our “Trust, Commitment, Results” philosophy.
Executive Summary
For the third quarter of fiscal year 2020, the Company reported total revenue of $111.5 million, compared to $108.0 million in the same period of fiscal year 2019.
During the third quarter of fiscal 2020, we continued to win significant new business from EMS competitors and from existing customers, including new programs involving consumer products, home exercise equipment, and personal safety equipment.
To prepare for growth in coming quarters, we continue to invest in new capacity in our Mexico, US and new Vietnam facilities, including a significant increase in our sheet metal capacity to address demand. We remain optimistic about our opportunities for growth in fiscal 2020 and beyond.
The concentration of our top three customers’ net sales decreased to 34.7 percent of total sales in the third quarter of fiscal year 2020 from 39.1 percent in the same period of the prior fiscal year.
21

Net sales to our largest customers may vary significantly from quarter to quarter depending on the size and timing of customer program commencement, forecasts, delays, and design modifications. We remain dependent on continued net sales to our significant customers and most contracts with customers are not firm long-term purchase commitments. We seek to maintain flexibility in production capacity by employing skilled temporary and short-term labor and by utilizing short-term leases on equipment and manufacturing facilities. In addition, our capacity and core competencies for printed circuit board assemblies, precision molding, sheet metal fabrication, tool making, assembly, and engineering can be applied to a wide variety of products.
Gross profit as a percent of net sales was 8.3 percent for the third quarter of fiscal year 2020 as compared to 6.3 percent for the same quarter of the prior fiscal year. The increase in gross profit as a percentage of net sales was primarily a result of increased revenue and streamlining efforts in the Company’s Juarez facilities.
Operating income as a percentage of net sales was 1.6 percent for the third quarter of fiscal year 2020 compared to (11.6) percent of operating income as a percentage of net sales for the third quarter of fiscal year 2019. Due to accounting requirements, the Company wrote down its goodwill and intangibles by approximately $12.5 million in the third quarter of 2019. Without the write down, operating margins would have been approximately break-even. The increase in operating income as a percentage of net sales was primarily driven by increased revenues compared to the same quarter of fiscal year 2019 and streamlining efforts in the Company’s Juarez facilities.
Net income for the third quarter of fiscal year 2020 was $0.9 million or $0.08 per share, as compared to net income of $(12.0) million or $(1.11) per share for the third quarter of fiscal year 2019.
As previously announced, the lower than anticipated revenue and earnings for third quarter of fiscal 2020 is primarily a result of disruptions to supply chains in China caused by the COVID-19 crisis, which delayed the arrival of key components. In addition, earnings in the third quarter of 2020 were impacted by a write down of $0.6 million of receivables from a customer that was impacted by the pandemic, decreasing earnings per share by approximately $0.04 per share.
Our pipeline of potential new business is also increasingly robust, involving programs with greater long-term revenue potential and higher quantity requirements. Our increased competitiveness in the EMS marketplace is being driven by the growing recognition of the advantages of North American and Vietnam based production, opportunities presented by the acquisition of Ayrshire, as well as by the growing number of opportunities where we can capitalize on the continued expansion of our sheet metal fabrication capabilities in concert with our plastic molding, printed circuit, and product assembly capabilities. We believe that we are well positioned in the EMS industry to continue expansion of our customer base and achieve long-term growth.
Due to the COVID-19 crisis, the Company has seen extreme shifts in demand from our customer base. Some customers have significantly increased their demand, including programs for home-consumer products, healthcare and home exercise equipment. Other customers, particularly those in the gaming industry, have seen large decreases in their demand. The effect of the virus on our customer’s demand is net positive, but each customer’s demand continues to change rapidly. Further, the costs of responding to this rapidly changing demand in the COVID-19 environment are unusually unpredictable. Freight and expedite costs, along with overtime and precautionary safety expenses, and collectability of accounts are impacting our results.
During the fourth quarter of fiscal year 2020, the Company announced the temporary closure of its Juarez facilities, however, operations successfully resumed six days later after petitioning the Mexican government to recognize the essential products the Company manufactures. Under U.S. regulations the Company is classified as an Essential Critical Infrastructure Employer and its Juarez facilities do manufacture essential products which are sold in Mexico. The Company has since ramped operations back up in Mexico while continuing to focus on protecting the health of all of its employees by adhering to current health guidelines.
Currently, the Company’s China facilities appear to be returning to full operation and the supply chain disruptions have been abating. The Company’s facilities in the US and Vietnam continue to operate normally, while we rigorously follow current health guidelines. We continue to invest in new capacity and remain optimistic about our long-term opportunities for growth. Nevertheless, uncertainty over the possibility of future temporary closures, predicting customer demand and costs, and predicting future supply chain disruptions during the rapidly changing COVID-19 environment makes it impossible to provide any specific guidance for the fourth quarter at this time. Future results will depend on actual levels of customers’ orders and the timing of the startup of production of new product programs.
On March 27, 2020, the Coronavirus Aid, Relief, and Economic Security Act (CARES Act) was enacted in response to the COVID-19 pandemic. The Company is continuing to evaluate the CARES Act, and at this time does not believe it will have a material impact on our consolidated financial position, results of operations, or cash flows. Refer to footnote 6 Income Taxes for discussion.
22

We maintain a strong balance sheet with a current ratio of 2.3 and a debt to equity ratio of 0.6 as of March 28, 2020. Total cash used in operating activities as defined on our cash flow statement was $32.1 million for the nine months ended March 28, 2020. We maintain sufficient liquidity for our expected future operations and had $57.2 million in borrowings and $0.4 million in outstanding letters of credit on our $65.0 million revolving line of credit with Wells Fargo Bank, N.A. of which $7.4 million remained available at March 28, 2020.
CRITICAL ACCOUNTING POLICIES AND ESTIMATES
Preparation of our consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires us to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses and the disclosure of contingent assets and liabilities. These estimates and assumptions are based on historical results as well as future expectations. Actual results could vary from our estimates and assumptions.
The accounting policies and estimates listed below are those that we believe are the most critical to our consolidated financial condition and results of operations. They are also the accounting policies that typically require our most difficult, subjective and complex judgments and estimates, often for matters that are inherently uncertain.

• | Revenue Recognition

• | Inactive, Obsolete, and Surplus Inventory Reserve

• | Allowance for Doubtful Accounts

• | Accrued Warranty

• | Income Taxes

• | Share-Based Compensation

• | Impairment of Long-Lived Assets

• | Derivatives and Hedging Activity

• | Long-Term Incentive Compensation Accrual

• | Impairment of Goodwill

Please refer to the discussion of critical accounting policies in our most recent Annual Report on Form 10-K for the fiscal year ended June 29, 2019, for further details. There were no changes to our accounting policies other than the adoption of ASC 842 as follows:
Leases
Refer to footnote 2 Significant Accounting Policies and footnote 14 Leases for critical accounting policies related to the adoption of ASC 842.
23

RESULTS OF OPERATIONS
Comparison of the Three Months Ended March 28, 2020 with the Three Months Ended March 30, 2019
The financial information and discussion below should be read in conjunction with the Consolidated Financial Statements and Notes.
The following table sets forth certain information regarding the components of our condensed consolidated statements of income for the three months ended March 28, 2020 as compared to the three months ended March 30, 2019. It is provided to assist in assessing differences in our overall performance (in thousands):

| Three Months Ended
| March 28, 2020 |  | % of net sales |  | March 30, 2019 |  | % of net sales |  | $ change |  | % point change
Net sales | $ | 111,455 |  |  | 100.0 | % |  | $ | 107,954 |  |  | 100.0 | % |  | $ | 3,501 |  |  | — | %
Cost of sales | 102,207 |  |  | 91.7 | % |  | 101,147 |  |  | 93.7 | % |  | 1,060 |  |  | (2.0 | )%
Gross profit | 9,248 |  |  | 8.3 | % |  | 6,807 |  |  | 6.3 | % |  | 2,441 |  |  | 2.0 | %
Research, development and engineering | 1,749 |  |  | 1.6 | % |  | 1,398 |  |  | 1.3 | % |  | 351 |  |  | 0.3 | %
Selling, general and administrative | 5,735 |  |  | 5.1 | % |  | 5,497 |  |  | 5.1 | % |  | 238 |  |  | — | %
Impairment of goodwill and intangibles | — |  |  | — | % |  | 12,448 |  |  | 11.5 | % |  | (12,448 | ) |  | (11.5 | )%
Total operating expenses | 7,484 |  |  | 6.7 | % |  | 19,343 |  |  | 17.9 | % |  | (11,859 | ) |  | (11.2 | )%
Operating income (loss) | 1,764 |  |  | 1.6 | % |  | (12,536 | ) |  | (11.6 | )% |  | 14,300 |  |  | 13.2 | %
Interest expense, net | 754 |  |  | 0.7 | % |  | 720 |  |  | 0.7 | % |  | 34 |  |  | — | %
Income (loss) before income taxes | 1,010 |  |  | 0.9 | % |  | (13,256 | ) |  | (12.3 | )% |  | 14,266 |  |  | 13.2 | %
Income tax provision (benefit) | 100 |  |  | 0.1 | % |  | (1,275 | ) |  | (1.2 | )% |  | 1,375 |  |  | 1.3 | %
Net income (loss) | $ | 910 |  |  | 0.8 | % |  | $ | (11,981 | ) |  | (11.1 | )% |  | $ | 12,891 |  |  | 11.9 | %
Effective income tax rate | 9.9 | % |  |  |  | 9.6 | % |  |  |  |  |  |

Net Sales
Net sales of $111.5 million for the third quarter of fiscal year 2020 increased by 3.2 percent as compared to net sales of $108.0 million for the third quarter of fiscal year 2019.
The $3.5 million increase in net sales from the prior year period was driven by an increase in demand for new program wins and increased demand from current customers.
Gross Profit
Gross profit as a percentage of net sales for the three months ended March 28, 2020 was 8.3 percent compared to 6.3 percent for the three months ended March 30, 2019. This 2.0 percentage point increase was due to a year over year increase in revenue and streamlining efforts in the Company’s Juarez facilities.
The level of gross margin is impacted by facility utilization, product mix, timing, severity and steepness of new program ramps, pricing within the electronics industry and material costs, which can fluctuate significantly from quarter to quarter.
Included in gross profit are charges related to changes in the allowance for obsolete inventory. We recorded a provision of approximately $35,000 and $12,000 for obsolete inventory during the three months ended March 28, 2020 and March 30, 2019, respectively. We adjust the allowance for estimated obsolescence as necessary in an amount equal to the difference between the cost of inventory and estimated net realizable value based on assumptions as to future demand and market conditions. The reserves are established for inventory that we have determined customers are not contractually responsible for and for inventory that we believe customers will be unable to purchase.
24

Operating Expenses
Total research, development, and engineering (RD&E) expenses were $1.7 million during the three months ended March 28, 2020 and $1.4 million during the three months ended March 30, 2019, respectively. Total RD&E expenses as a percent of net sales were 1.6 percent during the three months ended March 28, 2020 and 1.3 percent during the three months ended March 30, 2019.
Total selling, general and administrative (SG&A) expenses were $5.7 million during the three months ended March 28, 2020 compared to $5.5 million for the three months ended March 30, 2019. Total SG&A expenses for the three months ended March 28, 2020, were impacted by a write down of $0.6 million of receivables from a customer that was affected by the COVID-19 pandemic. Total SG&A expenses as a percentage of net sales were 5.1 percent for the three months ended March 28, 2020 and for the three months ended March 30, 2019; respectively.
Interest
Interest expense was $0.8 million during the three months ended March 28, 2020 and $0.7 million during the three months ended March 30, 2019. The increase in interest expense is primarily related to an increase in the average balance outstanding on our line of credit.
Income Taxes
The effective tax rate for the three months ended March 28, 2020 was 9.9 percent compared to 9.6 percent for the three months ended March 30, 2019. The increase was primarily due to the impact of the goodwill write-off that was recorded in the prior year. For further information on taxes see footnote 6 of the “Notes to Consolidated Financial Statements.”
Our judgments regarding deferred tax assets and liabilities may change due to changes in market conditions, changes in estimates, changes in tax laws or other factors. If assumptions and estimates change in the future the deferred tax assets and liability will be adjusted accordingly and any increase or decrease will result in an additional deferred income tax expense or benefit in subsequent periods.
RESULTS OF OPERATIONS
Comparison of the Nine Months Ended March 28, 2020 with the Nine Months Ended March 30, 2019
The financial information and discussion below should be read in conjunction with the Consolidated Financial Statements and Notes.
The following table sets forth certain information regarding the components of our condensed consolidated statements of income (loss) for the nine months ended March 28, 2020 as compared to the nine months ended March 30, 2019. It is provided to assist in assessing differences in our overall performance (in thousands):

| Nine Months Ended
| March 28, 2020 |  | % of net sales |  | March 30, 2019 |  | % of net sales |  | $ change |  | % point change
Net sales | $ | 333,462 |  |  | 100.0 | % |  | $ | 358,463 |  |  | 100.0 | % |  | $ | (25,001 | ) |  | — | %
Cost of sales | 306,819 |  |  | 92.0 | % |  | 332,243 |  |  | 92.7 | % |  | (25,424 | ) |  | (0.7 | )%
Gross profit | 26,643 |  |  | 8.0 | % |  | 26,220 |  |  | 7.3 | % |  | 423 |  |  | 0.7 | %
Research, development and engineering | 5,129 |  |  | 1.5 | % |  | 4,955 |  |  | 1.4 | % |  | 174 |  |  | 0.1 | %
Selling, general and administrative | 15,713 |  |  | 4.7 | % |  | 16,184 |  |  | 4.5 | % |  | (471 | ) |  | 0.2 | %
Impairment of goodwill and intangibles | — |  |  | — | % |  | 12,448 |  |  | 3.5 | % |  | (12,448 | ) |  | (3.5 | )%
Total operating expenses | 20,842 |  |  | 6.2 | % |  | 33,587 |  |  | 9.4 | % |  | (12,745 | ) |  | (3.2 | )%
Operating income (loss) | 5,801 |  |  | 1.7 | % |  | (7,367 | ) |  | (2.1 | )% |  | 13,168 |  |  | 3.8 | %
Interest expense, net | 1,988 |  |  | 0.6 | % |  | 2,105 |  |  | 0.6 | % |  | (117 | ) |  | — | %
Income (loss) before income taxes | 3,813 |  |  | 1.1 | % |  | (9,472 | ) |  | (2.6 | )% |  | 13,285 |  |  | 3.7 | %
Income tax provision (benefit) | 527 |  |  | 0.2 | % |  | (673 | ) |  | (0.2 | )% |  | 1,200 |  |  | 0.4 | %
Net income (loss) | $ | 3,286 |  |  | 1.0 | % |  | $ | (8,799 | ) |  | (2.5 | )% |  | $ | 12,085 |  |  | 3.5 | %
Effective income tax rate | 13.8 | % |  |  |  | 7.1 | % |  |  |  |  |  |

25

Net Sales
Net sales of $333.5 million for the nine months ended March 28, 2020 decreased by 7.0 percent as compared to net sales of $358.5 million for the nine months ended March 30, 2019.
The $25.0 million decrease in net sales from the prior year period was driven both by an increase in the demand for sheet metals causing workload balancing challenges in Q2, as well as disruptions to supply chains in China caused by the COVID-19 crisis, which delayed the arrival of key components.
Gross Profit
Gross profit as a percentage of net sales for the nine months ended March 28, 2020 was 8.0 percent compared to 7.3 percent for the nine months ended March 30, 2019. This 0.7 percentage point increase is primarily related to streamlining efforts in the Company’s Juarez facilities. The level of gross margin is impacted by facility utilization, product mix, timing, severity and steepness of new program ramps, pricing within the electronics industry and material costs, which can fluctuate significantly from quarter to quarter.
Included in gross profit are charges related to changes in the allowance for obsolete inventory. We recorded a provision of approximately $76,000 and $70,000 for obsolete inventory during the nine months ended March 28, 2020 and March 30, 2019, respectively. We adjust the allowance for estimated obsolescence as necessary in an amount equal to the difference between the cost of inventory and estimated market value based on assumptions as to future demand and market conditions. The reserves are established for inventory that we have determined customers are not contractually responsible for and for inventory that we believe customers will be unable to purchase.
Operating Expenses
Total research, development, and engineering (RD&E) expenses were $5.1 million and $5.0 million during the nine months ended March 28, 2020 and March 30, 2019, respectively. Total RD&E expenses as a percent of net sales were 1.5 percent during the nine months ended March 28, 2020 and the nine months ended March 30, 2019; respectively.
Total selling, general and administrative (SG&A) expenses were $15.7 million during the nine months ended March 28, 2020 compare to $16.2 million for the nine months ended March 30, 2019. Total SG&A expenses for the nine months ended March 30, 2019, were impacted by a write down of $0.6 million of receivables from a customer that was affected by the pandemic. Total SG&A expenses as a percentage of net sales were 4.7 percent during the nine months ended March 28, 2020 compared to 4.5 percent during the nine months ended March 30, 2019. This 0.2 percentage point increase in SG&A is related to a decrease is revenue from prior year.
Interest
Interest expense was $2.0 million during the nine months ended March 28, 2020 compared to $2.1 million during the nine months ended March 30, 2019. The decrease in interest expense is primarily related to a decrease in the average balance outstanding on our line of credit.
Income Taxes
The effective tax rate for the nine months ended March 28, 2020 was 13.8 percent compared to 7.1 percent for the same period in fiscal year 2019. The effective tax rate increased from the prior year primarily due to the impact of the goodwill write-off that was recorded in the prior year. For further information on taxes see footnote 6 of the “Notes to Consolidated Financial Statements.” Refer to footnote 12 for additional information relating to the write-off of certain intangible assets.
Our judgments regarding deferred tax assets and liabilities may change due to changes in market conditions, changes in estimates, changes in tax laws or other factors. If assumptions and estimates change in the future the deferred tax assets and liability will be adjusted accordingly and any increase or decrease will result in an additional deferred income tax expense or benefit in subsequent periods. Considering the economic impacts of the COVID-19 crisis, Management assessed the realizability of all deferred tax assets at March 28, 2020, and determined that it is more likely than not that the deferred tax assets will be realized. Therefore, a valuation allowance is not required at March 28, 2020.
BACKLOG
On March 28, 2020, we had an order backlog of approximately $208.1 million. This compares with a backlog of approximately $151.5 million on March 30, 2019. The increase in order backlog was related to the effect of the COVID-19 pandemic on our customer’s demand resulting in a net positive, as the Company saw significant increases in demand from programs for home-consumer products, healthcare and home exercise equipment. Order backlog consists of purchase orders received for products expected to be shipped within the next 12 months, although shipment dates are subject to change due to design modifications or changes in other customer requirements. Order backlog should not be considered an accurate measure of future net sales.
26

CAPITAL RESOURCES AND LIQUIDITY
Operating Cash Flow
Net cash used in operating activities for the nine months ended March 28, 2020 was $32.1 million, compared to net cash provided by operating activities of $3.4 million during the same period of the prior fiscal year.
The $32.1 million of net cash used in operating activities for the nine months ended March 28, 2020 is primarily related to $3.3 million in net income for the period adjusted for $4.0 million of depreciation and amortization, a $1.7 million decrease in accounts payable, $4.5 million decrease in contract assets, offset by a $13.7 million increase in inventory and a $19.5 million increase in accounts receivable. The $19.5 million increase in accounts receivable is a direct result of the Company not factoring receivables during the third quarter fiscal year 2020.
This compares to $3.4 million of net cash provided by operating activities for the nine months ended March 30, 2019 is primarily related to $8.8 million in net loss for the period adjusted for $12.4 million impairment of goodwill and intangibles,$5.5 million of depreciation and amortization, $6.7 million of cash received from arbitration settlement, $5.5 million decrease in accounts receivable, a $3.6 million decrease in inventory, partially offset by an $8.2 million increase in contract assets, a $7.4 million decrease in accounts payable, a $3.6 million increase in other assets, and a $1.8 million decrease in accrued compensation.
Accounts receivable fluctuates based on the timing of shipments, terms offered and collections that occurred during the quarter. While overall net sales are not typically seasonal in nature, we ship the majority of our product during the latter half of the quarter. In addition, accounts receivable will fluctuate based upon the amount of accounts receivable sold under our trade accounts receivable purchase programs. During the nine months ended March 28, 2020 and March 30, 2019, we factored accounts receivable of $38.6 million and $62.0 million, respectively, which were removed from our Consolidated Balance Sheets. The $23.4 million year over year decrease in factored receivables is a direct result of the Company not factoring receivables during the third quarter fiscal year 2020 coupled with the year over year decrease in revenue. We purchase inventory based on customer forecasts and orders, and when those forecasts and orders change, the amount of inventory may also fluctuate. Accounts payable fluctuates with changes in inventory levels, volume of inventory purchases and negotiated supplier terms.
Investing Cash Flow
Cash used in investing activities was $0.9 million during the nine months ended March 28, 2020 as compared to cash used in investing activities of $1.1 million during the nine months ended March 30, 2019. Our primary investing activity during the nine months ended March 28, 2020 and March 30, 2019, was purchasing equipment to support increased production levels for new programs.
Leases are often utilized when potential technical obsolescence and funding requirement advantages outweigh the benefits of equipment ownership. Capital expenditures and periodic lease payments are expected to be financed with internally generated funds as well as our revolving line of credit facility and equipment term loan.
Financing Cash Flow
Cash provided by financing activities was $33.6 million during the nine months ended March 28, 2020 as compared to cash used in financing activities of $2.5 million in the same period of the previous fiscal year. Our primary financing activities during the nine months ended March 28, 2020 and nine months ended March 30, 2019, were borrowings and repayments under our revolving line of credit facility and term loans. The increase in Company borrowings is a result of the Company no longer factoring receivables as of the third quarter fiscal year 2020 coupled with increased inventory balances. Our credit agreement with Wells Fargo Bank N.A. provides a revolving line of credit facility of up to $65.0 million, subject to availability.
As of March 28, 2020, approximately $7.4 million was available under the revolving line of credit facility. As of March 30, 2019, approximately $26.5 million was available under the revolving line of credit facility.
Our cash requirements are affected by the level of current operations and new EMS programs. We believe that projected cash from operations, funds available under the revolving credit facility and leasing capabilities will be sufficient to meet our working and fixed capital requirements for the foreseeable future. The Company further notes the positive impact of COVID-19 on projected cash from operations from increased demand from certain customers will be partially offset by an anticipated slowdown in collections from others. As of March 28, 2020, we had approximately $1,215,000 of cash held by foreign subsidiaries. If cash is to be repatriated in the future from these foreign subsidiaries, the Company would be subject to certain withholding taxes in the foreign jurisdictions. The total amount of tax payments required for the amount of foreign subsidiary cash on hand as of March 28, 2020 would approximate $122,000. We have accrued withholding taxes for expected future repatriation of foreign earnings as discussed in footnote 6 of the “Notes to Consolidated Financial Statements.”
27

OFF-BALANCE SHEET ARRANGEMENTS AND CONTRACTUAL OBLIGATIONS
We have included a summary of our Contractual Obligations in our annual report on Form 10-K for the fiscal year ended June 29, 2019. There have been no material changes in contractual obligations outside the ordinary course of business since June 29, 2019.
RISKS AND UNCERTAINTIES THAT MAY AFFECT FUTURE RESULTS
The following risks and uncertainties could affect our actual results and could cause results to differ materially from past results or those contemplated by our forward-looking statements. When used herein, the words “expects,” “believes,” “anticipates” and other similar expressions are intended to identify forward-looking statements.
We may experience fluctuations in quarterly results of operations.
Our quarterly operating results have varied in the past and may vary in the future due to a variety of factors, including adverse changes in the U.S. and global macroeconomic environment, volatility in overall demand for our customers’ products, success of customers’ programs, timing of new programs, new product introductions or technological advances by us, our customers and our competitors, and changes in pricing policies by us, our customers, our suppliers, and our competitors. Our customer base is diverse in the markets they serve, however, decreases in demand, particularly from customers in certain industries could affect future quarterly results. Additionally, our customers could be adversely impacted by illiquidity in the credit markets which could directly impact our operating results.
Component procurement, production schedules, personnel and other resource requirements are based on estimates of customer requirements. Occasionally, our customers may request accelerated production that can stress resources and reduce operating margins. Conversely, our customers may abruptly lower or cancel production which may lead to a sudden, unexpected increase in inventory or accounts receivable for which we may not be reimbursed even when under contract with customers. In addition, because many of our operating expenses are relatively fixed, a reduction in customer demand can harm our gross profit and operating results. The products which we manufacture for our customers have relatively short product lifecycles. Therefore, our business, operating results and financial condition are dependent in a significant way on our ability to obtain orders from new customers and new product programs from existing customers.
Operating results can also fluctuate if changes are made to significant estimates and assumptions. Significant estimates and assumptions include the allowance for doubtful receivables, provision for obsolete and non-saleable inventory, stock-based compensation, the valuation allowance on deferred tax assets, impairment of long-lived assets, long-term incentive compensation accrual, the provision for warranty costs, and the impact of hedging activities.
Due to the COVID-19 pandemic, we have seen extreme shifts in demand from our customer base. The possibility of future temporary closures, as well as the inability to predict customer demand, costs, and future supply chain disruptions during the rapidly changing COVID-19 environment can materially impact operating results.
We are exposed to general economic conditions, which could have a material adverse impact on our business, operating results and financial condition.
Adverse economic conditions and uncertainty in the global economy such as unstable global financial and credit markets, inflation, and recession can negatively impact our business. Unfavorable economic conditions could affect the demand for our customers’ products by triggering a reduction in orders as well as a decline in forecasts which could adversely affect our sales in future periods. Additionally, the financial strength of our customers and suppliers and their ability to obtain and rely on credit financing may affect their ability to fulfill their obligations to us and have an adverse effect on our financial results.
Adverse macroeconomic conditions as a result of COVID-19 can affect our business. The conditions can affect the Company’s ability to predict and plan for future supply chain disruptions, fluctuations in customer demand and costs, and the ability to operate as there is uncertainty over future temporary closures.
The majority of our sales come from a small number of customers and a decline in sales to any of these customers could adversely affect our business.
At present, our customer base is concentrated and could become more or less concentrated. There can be no assurance that our principal customers will continue to purchase products from us at current levels. Moreover, we typically do not enter into long-term volume purchase contracts with our customers, and our customers have certain rights to extend or delay the shipment of their orders. We, however, typically require that our customers contractually agree to buy back inventory purchased within specified lead times to build their products if not used.
28

The loss of one or more of our major customers, or the reduction, delay or cancellation of orders from such customers, due to economic conditions or other forces, could materially and adversely affect our business, operating results and financial condition. The contraction in demand from certain industries could impact our customer orders and have a negative impact on our operations over the foreseeable future. Additionally, if one or more of our customers were to become insolvent or otherwise unable to pay for the manufacturing services provided by us, our operating results and financial condition would be adversely affected.
We depend on a limited number of suppliers for certain components that are critical to our manufacturing processes. A shortage of these components or an increase in their price could interrupt our operations and result in a significant change in our results of operations.
We are dependent on many suppliers, including sole source suppliers, to provide key components and raw materials used in manufacturing customers’ products. We have seen supply shortages in certain electronic components. In addition, our suppliers' facilities may also experience earthquakes, tsunamis and other natural disasters which may cause a shortage of components. This can result in longer lead times and the inability to meet our customers request for flexible production and extended shipment dates. If demand for components outpaces supply, capacity delays could affect future operations. Delays in deliveries from suppliers or the inability to obtain sufficient quantities of components and raw materials could cause delays or reductions in shipment of products to our customers which could adversely affect our operating results and damage customer relationships.
Key Tronic is working closely with its employees and key suppliers to ascertain delays attributable to the COVID-19 pandemic. Potential delays in production and extended transit times of critical parts may cause a shortage of components.
We operate in a highly competitive industry; if we are not able to compete effectively in the EMS industry, our business could be adversely affected.
Competitors may offer customers lower prices on certain high volume programs. This could result in price reductions, reduced margins and loss of market share, all of which would materially and adversely affect our business, operating results, and financial condition. If we were unable to provide comparable or better manufacturing services at a lower cost than our competitors, it could cause sales to decline. In addition, competitors can copy our non-proprietary designs and processes after we have invested in development of products for customers, thereby enabling such competitors to offer lower prices on such products due to savings in development costs.
Cash and cash equivalents are exposed to concentrations of credit risk.
We place our cash with high credit quality institutions. At times, such balances may be in excess of the federal depository insurance limit or may be on deposit at institutions which are not covered by insurance. If such institutions were to become insolvent during which time it held our cash and cash equivalents in excess of the insurance limit, it could be necessary to obtain other credit financing to operate our facilities.
Our ability to secure and maintain sufficient credit arrangements is key to our continued operations.
There is no assurance that we will be able to retain or renew our credit agreements in the future. In the event the business grows rapidly or there is uncertainty in the macroeconomic climate, additional financing resources could be necessary in the current or future fiscal years. There is no assurance that we will be able to obtain equity or debt financing at acceptable terms, or at all in the future. In addition, we have restrictive covenants with our financial institution which could impact how we manage our business. If we cannot meet our financial covenants, our borrowings could become immediately payable which could have a material adverse impact on our financial statements. For a summary of our banking arrangements, see Note 4 Long-Term Debt of the “Notes to Consolidated Financial Statements.”
29

Our operations may be subject to certain risks.
We manufacture product in facilities located in Mexico, China and the United States. These operations may be subject to a number of risks, including:

• | difficulties in staffing, turnover and managing onshore and offshore operations;

• | political and economic instability (including acts of terrorism, pandemics, civil unrest, forms of violence and outbreaks of war), which could impact our ability to ship, manufacture, and/or receive product;

• | unexpected changes in regulatory requirements and laws;

• | longer customer payment cycles and difficulty collecting accounts receivable;

• | export duties, import controls and trade barriers (including quotas);

• | governmental restrictions on the transfer of funds;

• | burdens of complying with a wide variety of foreign laws and labor practices;

• | our locations may be impacted by hurricanes, tornadoes, earthquakes, water shortages, tsunamis, floods, typhoons, fires, extreme weather conditions and other natural or man-made disasters. Our locations may also by impacted by future temporary closures as a result of COVID-19.

Our operations in certain foreign locations receive favorable income tax treatment in the form of tax credits or other incentives. In the event that such tax incentives are not extended, are repealed, or we no longer qualify for such programs, our taxes may increase, which would reduce our net income.
Additionally, certain foreign jurisdictions restrict the amount of cash that can be transferred to the U.S or impose taxes and penalties on such transfers of cash. To the extent we have excess cash in foreign locations that could be used in, or is needed by, our operations in the United States, we may incur significant penalties and/or taxes to repatriate these funds.
Fluctuations in foreign currency exchange rates could increase our operating costs.
We have manufacturing operations located in Mexico and China. A significant portion of our operations are denominated in the Mexican peso and the Chinese currency, the renminbi ("RMB"). Currency exchange rates fluctuate daily as a result of a number of factors, including changes in a country's political and economic policies. Volatility in the currencies of our entities and the United States dollar could seriously harm our business, operating results and financial condition. The primary impact of currency exchange fluctuations is on the cash, receivables, payables and expenses of our operating entities. As part of our hedging strategy, we currently use Mexican peso forward contracts to hedge foreign currency fluctuations for a portion of our Mexican peso denominated expenses. We currently do not hedge expenses denominated in RMB. Unexpected losses could occur from increases in the value of these currencies relative to the United States dollar.
As a result of COVID-19, significant currency exchange fluctuations can occur causing unexpected losses. Future temporary closures of production facilities in Mexico could also cause significant changes in our ability to qualify for hedge accounting treatment of our forward contracts to hedge foreign currency fluctuations. However, given the unprecedented nature of the pandemic the FASB staff believes that an entity may apply the exception in paragraph 815-30-40-4 for rare cases caused by extenuating circumstances that are related to the nature of the forecasted transaction and are outside the control or influence of an entity to delays in the timing of the forecasted transactions if those delays are related to the effects of the COVID-19 pandemic. In addition, the FASB staff believes that it would be acceptable for an entity to determine that missed forecasts related to the effects of the COVID-19 pandemic need not be considered when determining whether it has exhibited a pattern of missing forecasts that would call into question its ability to accurately predict forecasted transactions and the propriety of using cash flow hedge accounting in the future for similar transactions.
Our success will continue to depend to a significant extent on our key personnel.
Our future success depends in large part on the continued service of our key technical, marketing and management personnel and on our ability to continue to attract and retain qualified production employees. There can be no assurance that we will be successful in attracting and retaining such personnel, particularly in our manufacturing locales that may be experiencing high demand for similar key personnel. The loss of key employees could have a material adverse effect on our business, operating results and financial condition.
30

If we are unable to maintain our technological and manufacturing process expertise, our business could be adversely affected.
The markets for our customers’ products are characterized by rapidly changing technology, evolving industry standards, frequent new product introductions and short product life cycles. The introduction of products embodying new technologies or the emergence of new industry standards can render existing products obsolete or unmarketable. Our success will depend upon our customers’ ability to enhance existing products and to develop and introduce, on a timely and cost-effective basis, new products that keep pace with technological developments and emerging industry standards and address evolving and increasingly sophisticated customer requirements. Failure of our customers to do so could substantially harm our customers’ competitive positions. There can be no assurance that our customers will be successful in identifying, developing and marketing products that respond to technological change, emerging industry standards or evolving customer requirements.
Start-up costs and inefficiencies related to new or transferred programs can adversely affect our operating results and such costs may not be recoverable if such new programs or transferred programs are canceled or don’t meet expected sales volumes.
Start-up costs, the management of labor and equipment resources in connection with the establishment of new programs and new customer relationships, and the need to obtain required resources in advance can adversely affect our gross margins and operating results. These factors are particularly evident in the ramping stages of new programs. These factors also affect our ability to efficiently use labor and equipment. We are currently managing a number of new programs. Consequently, our exposure to these factors has increased. In addition, if any of these new programs or new customer relationships were terminated, our operating results could be harmed, particularly in the short term. We may not be able to recoup these start-up costs or replace anticipated new program revenues.
Customers may change production timing and demand schedules which makes it difficult for us to schedule production and capital expenditures and to maximize the efficiency of our manufacturing capacity.
Changes in demand for customer products reduce our ability to accurately estimate the future requirements of our customers. This makes it difficult to schedule production and maximize utilization of our manufacturing capacity. We must determine the levels of business that we will seek and accept from customers, set production schedules, commit to procuring inventory, and allocate personnel and resources, based on our estimates of our customers' requirements. Customers can require sudden increases and decreases in production which can put added stress on resources and reduce margins. Sudden decreases in production can lead to excess inventory on hand which may or may not be reimbursed by our customers even when under contract.
Continued growth could further lead to capacity constraints. We may need to transfer production to other facilities, acquire new facilities, or outsource production which could negatively impact gross margin. The Company has been able to manage the arrival of components in an effort to control inventory levels of customers that have seen sharp decreases in demand, as a result of COVID-19.
An adverse change in the interest rates for our borrowings could adversely affect our financial condition.
We are exposed to interest rate risk under our revolving line of credit and term loan. We currently hedge a portion of our term loan with an interest rate swap. We have not historically hedged the interest rate on our credit facility; therefore, unless we do so, significant changes in interest rates could adversely affect our results of operations. Refer to the discussion in note 4, "Long-Term Debt" to the consolidated financial statements for further details of our debt obligations. We are also exposed to interest rate risk on our factoring activities.
Compliance or the failure to comply with current and future environmental laws or regulations could cause us significant expense.
We are subject to a variety of domestic and foreign environmental regulations relating to the use, storage, and disposal of materials used in our manufacturing processes. If we fail to comply with any present or future regulations, we could be subject to future liabilities or the suspension of current manufacturing operations. In addition, such regulations could restrict our ability to expand our operations or could require us to acquire costly equipment, substitute materials, or incur other significant expenses to comply with government regulations.
To protect the health of its employees, the Company has implemented the recommendations of WHO and the CDC including wearing of face masks and shields, workstation arrangements to provide social distancing, temperature monitoring, enhanced worksite disinfection, spacing in cafeterias and break areas, contact management and other precautions. The Company is also in compliance with government regulations related to COVID-19.
31

Our stock price is volatile.
Holders of the common stock will suffer immediate dilution to the extent outstanding equity awards are exercised to purchase common stock. Our stock price may be subject to wide fluctuations and possible rapid increases or declines over a short time period. These fluctuations may be due to factors specific to us such as our stock's thinly traded nature, variations in quarterly operating results or changes in earnings estimates, or to factors relating to the EMS industry or to the securities markets in general, which, in recent years, have experienced significant price fluctuations. These fluctuations often have been unrelated to the operating performance of the specific companies whose stocks are traded.
Due to inherent limitations, there can be no assurance that our system of disclosure and internal controls and procedures will be successful in preventing all errors, theft and fraud, or in informing management of all material information in a timely manner.
Management does not expect that our disclosure controls and internal controls and procedures will prevent all errors or fraud. A control system is designed to give reasonable, but not absolute, assurance that the objectives of the control system are met. In addition, any control system reflects resource constraints and the benefits of controls must be considered relative to their costs. Inherent limitations of a control system may include: judgments in decision making may be faulty, breakdowns can occur simply because of error or mistake and controls can be circumvented by collusion or management override. Due to the inherent limitations in a cost-effective control system, misstatements due to error or fraud may occur and may not be detected.
If we do not manage our growth effectively, our profitability could decline.
Our business is experiencing growth which can place considerable additional demands upon our management team and our operational, financial and management information systems. Our ability to manage growth effectively requires us to continue to implement and improve these systems; avoid cost overruns; maintain customer, supplier and other favorable business relationships during possible transition periods; continue to develop the management skills of our managers and supervisors; and continue to train, motivate and manage our employees. Our failure to effectively manage growth could have a material adverse effect on our results of operations.
If our manufacturing processes and services do not comply with applicable statutory and regulatory requirements, or if we manufacture products containing design or manufacturing defects, demand for our services may decline and we may be subject to liability claims.
We manufacture and design products to our customers’ specifications, and, in some cases, our manufacturing processes and facilities may need to comply with applicable statutory and regulatory requirements. For example, medical devices that we manufacture or design, as well as the facilities and manufacturing processes that we use to produce them, are regulated by the Food and Drug Administration and non-U.S. counterparts of this agency. In addition, our customers’ products and the manufacturing processes that we use to produce them often are highly complex. As a result, products that we manufacture may at times contain manufacturing or design defects, and our manufacturing processes may be subject to errors or not be in compliance with applicable statutory and regulatory requirements. Defects in the products we manufacture or design, whether caused by a design, manufacturing or component failure or error, or deficiencies in our manufacturing processes, may result in delayed shipments to customers or reduced or canceled customer orders. If these defects or deficiencies are significant, our business reputation may also be damaged. The failure of the products that we manufacture or our manufacturing processes and facilities to comply with applicable statutory and regulatory requirements may subject us to legal fines or penalties and, in some cases, require us to shut down or incur considerable expense to correct a manufacturing process or facility. Our customers are required to indemnify us against liability associated with designing products to meet their specifications. However, if our customers are responsible for the defects, they may not, or may not have resources to, assume responsibility for any costs or liabilities arising from these defects, which could expose us to additional liability claims.
Energy price increases may negatively impact our results of operations.
Certain components that we use in our manufacturing process are petroleum-based. In addition, we, along with our suppliers and customers, rely on various energy sources in our transportation activities. While significant uncertainty currently exists about the future levels of energy prices, a significant increase is possible. Increased energy prices could cause an increase to our raw material costs and transportation costs. In addition, increased transportation costs related to certain suppliers and customers could be passed along to us. We may not be able to increase our product prices enough to offset these increased costs. In addition, any increase in our product prices may reduce our future customer orders and profitability.
32

Disruptions to our information systems, including security breaches, losses of data or outages, could adversely affect our operations.
We rely on information technology networks and systems to process, transmit and store electronic information. In particular, we depend on our information technology infrastructure for a variety of functions, including worldwide financial reporting, inventory management, procurement, invoicing and email communications. Any of these systems may be susceptible to outages due to fire, floods, power loss, telecommunications failures, terrorist attacks and similar events. Despite the implementation of network security measures, our systems and those of third parties on which we rely may also be vulnerable to computer viruses, break-ins and similar disruptions. If we or our vendors are unable to prevent such outages and breaches, our operations could be disrupted.
We are involved in various legal proceedings.
In the past, we have been notified of claims relating to various matters including contractual matters, intellectual property rights or other issues arising in the ordinary course of business. In the event of such a claim, we may be required to spend a significant amount of money to defend or otherwise address the claim. Any litigation or dispute resolution, even where a claim is without merit, could result in substantial costs and diversion of resources. Accordingly, the resolution or adjudication of such disputes, even those encountered in the ordinary course of business, could have a material effect on our business, consolidated financial conditions and results of operations.
Our levels of insurance coverage may not be sufficient for potential damages, claims or losses.
We have various forms of business and liability insurance which we believe are appropriate based on the needs of companies in our industry. As a result, not all of our potential business risks or potential losses would be covered by our insurance policies. If we sustain a significant claim or loss which is not covered by insurance, our net income could be negatively impacted.
Changes in securities laws and regulations will increase our costs and risk of noncompliance.
We are required to file as an accelerated filer. As such, we are subject to additional requirements contained in the Sarbanes-Oxley Act of 2002 (the Sarbanes-Oxley Act) and more recently the Dodd-Frank Act. The Sarbanes-Oxley and Dodd-Frank Acts required or will require changes in some of our corporate governance, securities disclosure and compliance practices. In response to the requirements of the Sarbanes-Oxley and Dodd-Frank Acts, the SEC and NASDAQ promulgated new rules and additional rulemaking is expected in the future. Compliance with these new rules and future rules has increased and may increase further our legal, financial and accounting costs as well as a potential risk of noncompliance. Absent significant changes in related rules, which we cannot assure, we anticipate some level of increased costs related to these new regulations to continue indefinitely. We also expect these developments to make it more difficult and more expensive to obtain director and officer liability insurance, and we may be forced to accept reduced coverage or incur substantially higher costs to obtain coverage. Likewise, these developments may make it more difficult for us to attract and retain qualified members of our Board of Directors or qualified management personnel. Further, the costs associated with the compliance with and implementation of procedures under these and future laws and related rules could have a material impact on our results of operations. In addition, the costs associated with noncompliance with additional securities laws and regulations could also impact our business.
We may encounter complications with acquisitions, which could potentially harm our business.
Any current or future acquisitions may require additional equity financing, which could be dilutive to our existing shareholders, or additional debt financing, which could potentially affect our credit ratings. Any downgrades in our credit ratings associated with an acquisition could adversely affect our ability to borrow by resulting in more restrictive borrowing terms. To integrate acquired businesses, we must implement our management information systems, operating systems and internal controls, and assimilate and manage the personnel of the acquired operations. The integration of acquired businesses may be further complicated by difficulties managing operations in geographically dispersed locations. The integration of acquired businesses may not be successful and could result in disruption by diverting management’s attention from the core business. In addition, the integration of acquired businesses may require that we incur significant restructuring charges or other increases in our expenses and working capital requirements, which reduce our return on invested capital.
Acquisitions may involve numerous other risks and challenges including but not limited to: potential loss of key employees and customers of the acquired companies; the potential for deficiencies in internal controls at acquired companies; lack of experience operating in the geographic market or industry sector of the acquired business; constraints on available liquidity, and exposure to unanticipated liabilities of acquired companies. These and other factors could harm our ability to achieve anticipated levels of profitability at acquired operations or realize other anticipated benefits of an acquisition, and could adversely affect our consolidated business and operating results.
33

Changes in financial accounting standards may affect our reported financial condition or results of operations as well increase costs related to implementation of new standards and modifications to internal controls.
Our consolidated financial statements are prepared in conformity with accounting standards generally accepted in the United States, or U.S. GAAP. These principles are subject to amendments made primarily by the Financial Accounting Standards Board (FASB) and the Securities and Exchange Commission (SEC). A change in those policies can have a significant effect on our reported results and may affect our reporting of transactions which are completed before a change is announced. Changes to accounting rules or challenges to our interpretation or application of the rules by regulators may have a material adverse effect on our reported financial results or on the way we conduct business. In addition, the continued convergence of U.S. GAAP and International Financial Reporting Standards (“IFRS”) creates uncertainty as to the financial accounting policies and practices we will need to adopt in the future.

Item 3. | Quantitative and Qualitative Disclosures About Market Risk

Interest Rate Risk
We are subject to the risk of fluctuating interest rates in the normal course of business. Our major market risk relates to our secured debt. Our revolving credit facility, term loan and equipment term loan are secured by substantially all of our assets. The interest rates applicable to our revolving credit facility, term loan and equipment term loan fluctuate with the Wells Fargo Bank, N.A. prime rate and LIBOR rates. There was outstanding $57.2 million in borrowings under our revolving credit facility, $11.7 million outstanding on our term loan and $1.1 million outstanding on our equipment term loan as of March 28, 2020. See “Management’s Discussion and Analysis of Financial Condition and Results of Operations – Capital Resources and Liquidity” and Note 4 – “Long-Term Debt” to the Consolidated Financial Statements for additional information regarding our revolving credit facility and term loans.
Foreign Currency Exchange Risk
A significant portion of our operations are in foreign locations. As a result, transactions occur in currencies other than the U.S. dollar. Exchange rate fluctuations among other currencies used by us would directly or indirectly affect our financial results. We currently use Mexican peso forward contracts to hedge foreign currency fluctuations for a portion of our Mexican peso denominated expenses. There was outstanding $43.0 million of foreign currency forward contracts as of March 28, 2020. The fair value of these contracts was $(2.4) million. See Note 10 – “Derivative Financial Instruments” to the Consolidated Financial Statements for additional information regarding our derivative instruments.

Item 4. | Controls and Procedures

It is the responsibility of our management to establish, maintain, and monitor disclosure controls and procedures that are designed to ensure that information required to be disclosed in our reports filed or submitted under the Securities Exchange Act of 1934 are recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission rules and forms. Additionally, these disclosure controls include controls and procedures that are designed to accumulate and communicate the information required to be disclosed to our company’s Chief Executive Officer and Chief Financial Officer, allowing for timely decisions regarding required disclosures. As of the end of the period covered by this report, our management carried out an evaluation, under the supervision and with the participation of the Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures pursuant to Exchange Act Rule 13a-15(f). Based on our assessment, we believe that as of March 28, 2020, the Company’s disclosure controls and procedures are effective based on that criteria.
Due to inherent limitations of any internal control system, management acknowledges that there are limitations as to the effectiveness of internal controls over financial reporting and therefore recognize that only reasonable assurance can be gained from any internal control system. Accordingly, our internal control system may not detect or prevent material misstatements in our financial statements and projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.
Changes in Internal Control over Financial Reporting
There have been no significant changes in our internal controls over financial reporting during the three months ended March 28, 2020 that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting (as defined in Exchange Act Rules 13a – 15(f) and 15d – 15(f)).
34

PART II. OTHER INFORMATION:

Item 1. | Legal Proceedings

We are involved in various legal actions arising in the ordinary course of business. In the opinion of management, the ultimate disposition of these matters will not have a material adverse effect on our consolidated financial position, results of operations or cash flows.

Item 1A. | Risk Factors

Information regarding risk factors appear in Item 2, “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and Item 3, “Quantitative and Qualitative Disclosures about Market Risk” of this Form 10-Q.
There are no material changes to the risk factors set forth in Part I Item 1A in the Company’s Annual Report on Form 10-K for the year ended June 29, 2019.

Item 6. |  | Exhibits |  |
|  | 31.1 |  | Certification of Chief Executive Officer (Exchange Act Rules 13(a)-14 and 15(d)-14)
|  | 31.2 |  | Certification of Chief Financial Officer (Exchange Act Rules 13(a)-14 and 15(d)-14)
|  | 32.1 |  | Certification of Chief Executive Officer (18 U.S.C. 1350)
|  | 32.2 |  | Certification of Chief Financial Officer (18 U.S.C. 1350)
|  | 101.INS |  | XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.
|  | 101.SCH |  | XBRL Taxonomy Extension Schema Document *
|  | 101.CAL |  | XBRL Taxonomy Extension Calculation Linkbase Document *
|  | 101.DEF |  | XBRL Taxonomy Extension Definition Linkbase Document *
|  | 101.LAB |  | XBRL Taxonomy Extension Label Linkbase Document *
|  | 101.PRE |  | XBRL Taxonomy Extension Presentation Linkbase Document *
|  | 104 |  | Cover Page Interactive Data File (formatted as inline XBRL with applicable taxonomy extention information contained in Exhibits 101.INS, 101.SCH, 101.CAL, 101.DEF, 101.LAB and 101.PRE)

* Pursuant to Rule 406T of Regulation S-T, these interactive data files are deemed not filed or part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933, as amended, or Section 18 of the Securities and Exchange Act of 1934, as amended and otherwise are not subject to liability under those sections.
35

SIGNATURES
Pursuant to the requirements of the Securities and Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned thereunto duly authorized.

KEY TRONIC CORPORATION
/s/ C RAIG D. G ATES |  |  |
Craig D. Gates |  | Date: | May 6, 2020
President and Chief Executive Officer |  |  |
(Principal Executive Officer) |  |  |
/s/ Brett R. Larsen |  |  |
Brett R. Larsen |  | Date: | May 6, 2020
Executive Vice President of Administration, Chief Financial Officer and Treasurer |  |  |
(Principal Financial Officer) |  |  |

36